<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Sports (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Sports (Basel)</journal-id><journal-id journal-id-type="publisher-id">sports</journal-id><journal-title-group><journal-title>Sports</journal-title></journal-title-group><issn pub-type="epub">2075-4663</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39997971</article-id><article-id pub-id-type="pmc">PMC11860767</article-id>
<article-id pub-id-type="doi">10.3390/sports13020040</article-id><article-id pub-id-type="publisher-id">sports-13-00040</article-id><article-categories><subj-group subj-group-type="heading"><subject>Systematic Review</subject></subj-group></article-categories><title-group><article-title>A Systematic Review and Meta-Analysis on Aerobic Fitness Dynamics in Post-COVID-19 Athletes: Implications in the Return-to-Play Performance</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lopes</surname><given-names>Lucas Rafael</given-names></name><xref rid="af1-sports-13-00040" ref-type="aff">1</xref><xref rid="af2-sports-13-00040" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3010-8373</contrib-id><name><surname>Medeiros</surname><given-names>Rui</given-names></name><xref rid="af3-sports-13-00040" ref-type="aff">3</xref><xref rid="af4-sports-13-00040" ref-type="aff">4</xref><xref rid="af5-sports-13-00040" ref-type="aff">5</xref><xref rid="af6-sports-13-00040" ref-type="aff">6</xref><xref rid="af7-sports-13-00040" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3680-7757</contrib-id><name><surname>Tavares</surname><given-names>Val&#x000e9;ria</given-names></name><xref rid="af3-sports-13-00040" ref-type="aff">3</xref><xref rid="af4-sports-13-00040" ref-type="aff">4</xref><xref rid="af5-sports-13-00040" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4993-4467</contrib-id><name><surname>Dias</surname><given-names>Francisca</given-names></name><xref rid="af3-sports-13-00040" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-7301-3644</contrib-id><name><surname>Amaral</surname><given-names>Marcus Vin&#x000ed;cius Galv&#x000e3;o</given-names></name><xref rid="af8-sports-13-00040" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><name><surname>Goes</surname><given-names>Rodrigo Ara&#x000fa;jo</given-names></name><xref rid="af8-sports-13-00040" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4088-044X</contrib-id><name><surname>Matheus Guimar&#x000e3;es</surname><given-names>Jo&#x000e3;o Antonio</given-names></name><xref rid="af8-sports-13-00040" ref-type="aff">8</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7683-0698</contrib-id><name><surname>Perini</surname><given-names>Jamila Alessandra</given-names></name><xref rid="af1-sports-13-00040" ref-type="aff">1</xref><xref rid="af2-sports-13-00040" ref-type="aff">2</xref><xref rid="c1-sports-13-00040" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Duncan</surname><given-names>Michael</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-sports-13-00040"><label>1</label>Research Laboratory of Pharmaceutical Sciences (LAPESF), Pharmacy Department, Rio de Janeiro State University (UERJ), Rio de Janeiro 23070-200, Brazil; <email>lopes.rlucas02@gmail.com</email></aff><aff id="af2-sports-13-00040"><label>2</label>Program of Post-Graduation in Public Health and Environment, National School of Public Health, Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro 21041-210, Brazil</aff><aff id="af3-sports-13-00040"><label>3</label>Molecular Oncology and Viral Pathology Group, Research Center of IPO Porto (CI-IPOP), Pathology and Laboratory Medicine Department, Clinical Pathology SV,RISE@CI-IPOP (Health Research Network), Portuguese Oncology Institute of Porto (IPO Porto), Porto Comprehensive Cancer Centre (Porto.CCC), 4200-072 Porto, Portugal; <email>ruimedei@ipoporto.min-saude.pt</email> (R.M.); <email>valeria.tavares@ipoporto.min-saude.pt</email> (V.T.); <email>francisca.carvalho.dias@ipoporto.min-saude.pt</email> (F.D.)</aff><aff id="af4-sports-13-00040"><label>4</label>Faculty of Medicine, University of Porto (FMUP), 4200-072 Porto, Portugal</aff><aff id="af5-sports-13-00040"><label>5</label>ICBAS&#x02014;Instituto de Ci&#x000ea;ncias Biom&#x000e9;dicas Abel Salazar, Universidade do Porto, 4050-313 Porto, Portugal</aff><aff id="af6-sports-13-00040"><label>6</label>Research Department, Portuguese League Against Cancer (NRNorte), 4200-172 Porto, Portugal</aff><aff id="af7-sports-13-00040"><label>7</label>Faculty of Health Sciences, Fernando Pessoa University, 4200-150 Porto, Portugal</aff><aff id="af8-sports-13-00040"><label>8</label>Research Division, National Institute of Traumatology and Orthopaedics (INTO), Rio de Janeiro 20940-070, Brazil<email>jmatheusguimaraes@gmail.com</email> (J.A.M.G.)</aff><author-notes><corresp id="c1-sports-13-00040"><label>*</label>Correspondence: <email>jamila.machado@uerj.br</email> or <email>jamilaperini@yahoo.com.br</email></corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>13</volume><issue>2</issue><elocation-id>40</elocation-id><history><date date-type="received"><day>18</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>17</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>21</day><month>1</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Maximal oxygen uptake (<inline-formula><mml:math id="mm1" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max) assesses athletic performance; however, its values are inconsistent in post-COVID-19 athletes. This study aimed to analyze the dynamics of <inline-formula><mml:math id="mm2" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max in post-COVID-19 athletes. Observational studies were identified by screening the PubMed database published up to 17 July 2023. The initial electronic search found 320 studies. Of these, 26 employing the cardiopulmonary exercise test (CPET) to assess aerobic fitness were selected. Of the 2625 pooled athletes, 1464 were infected and considered as the post-COVID-19 group, either asymptomatic or symptomatic, while the remaining 1161, who were uninfected or had <inline-formula><mml:math id="mm11" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max results prior to infection, were defined as the infection-free group. Age and <inline-formula><mml:math id="mm3" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max were differently distributed between post-COVID-19 athletes and those without infection (<italic toggle="yes">p</italic> = 0.03 in both). Persistent symptoms athletes had 8 mL/Kg/min lower <inline-formula><mml:math id="mm12" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max than those without infection (<italic toggle="yes">p</italic> = 0.04). In addition, post-infected athletes who underwent CPET after 12 weeks showed a significant reduction of 2.9 mL/Kg/min in <inline-formula><mml:math id="mm5" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max according to the increase in body mass index (BMI). The pooled analysis showed that aerobic fitness was reduced in athletes post-COVID-19. <inline-formula><mml:math id="mm13" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max was negatively correlated with BMI in those who underwent CPET at 12 weeks, suggesting that symptoms persist beyond 12 weeks, affecting return-to-play.</p></abstract><kwd-group><kwd>COVID-19</kwd><kwd>athletes</kwd><kwd>performance</kwd><kwd>maximal oxygen uptake</kwd><kwd>aerobic fitness</kwd></kwd-group><funding-group><award-group><funding-source>Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior</funding-source></award-group><award-group><funding-source>European Social Funds (FSE) and national funds of MCTES</funding-source><award-id>2020.08969.BD</award-id></award-group><award-group><funding-source>FCT-Funda&#x000e7;&#x000e3;o para a Ci&#x000ea;ncia e Tecnologia</funding-source></award-group><award-group><funding-source>Brazilian agency Funda&#x000e7;&#x000e3;o Carlos Chagas Filho de Amparo &#x000e0; Pesquisa do Estado do Rio de Janeiro&#x02014;FAPERJ</funding-source><award-id>E-26/210.949/2021</award-id></award-group><award-group><funding-source>Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico (CNPq)</funding-source><award-id>309065/2021-6</award-id></award-group><award-group><funding-source>UERJ</funding-source></award-group><funding-statement>L.R.L. was a PhD scholarship holder supported by Coordena&#x000e7;&#x000e3;o de Aperfei&#x000e7;oamento de Pessoal de N&#x000ed;vel Superior (CAPES PrInt- Ficruz) (88887.842668/2023-00). V.T. was a PhD scholarship holder supported by FCT-Funda&#x000e7;&#x000e3;o para a Ci&#x000ea;ncia e Tecnologia, co-financed by European Social Funds (FSE) and national funds of MCTES (no. 2020.08969.BD; <uri xlink:href="https://doi.org/10.54499/2020.08969.BD">https://doi.org/10.54499/2020.08969.BD</uri>). F.D. has a junior researcher contract funded by FCT-Funda&#x000e7;&#x000e3;o para a Ci&#x000ea;ncia e Tecnologia. J.A.P., M.V.G.A., R.A.G., and J.A.M.G. were supported by the Brazilian agency Funda&#x000e7;&#x000e3;o Carlos Chagas Filho de Amparo &#x000e0; Pesquisa do Estado do Rio de Janeiro&#x02014;FAPERJ (E-26/210.949/2021), and J.A.P. was supported by the Conselho Nacional de Desenvolvimento Cient&#x000ed;fico e Tecnol&#x000f3;gico (CNPq) (309065/2021-6) and UERJ (Prociencia 2023-2026).</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-sports-13-00040"><title>1. Introduction</title><p>Coronavirus disease 2019 (COVID-19) has affected approximately 775.2 million people worldwide over three years (updated 24 March 2024). Even with 67% of the total global population vaccinated with a complete primary series and 32% with at least one booster dose of a COVID-19 vaccine, 42,388 individuals were infected from January to March 2024 [<xref rid="B1-sports-13-00040" ref-type="bibr">1</xref>]. This becomes a concern with the occurrence of major events, such as the Paris 2024 Olympic Games, where interaction between individuals from different countries may increase the number of cases and generate negative public health consequences, such as sequelae of infection [<xref rid="B2-sports-13-00040" ref-type="bibr">2</xref>]. Post-COVID-19 syndrome consists of persistent symptoms, including but not limited to breathlessness, increased oxygen requirements, post-viral cough, and cardiovascular muscular change, which can manifest for more than 12 weeks after the infection period [<xref rid="B3-sports-13-00040" ref-type="bibr">3</xref>,<xref rid="B4-sports-13-00040" ref-type="bibr">4</xref>]. Recent studies have shown that even asymptomatic and those with mild or moderate symptoms during acute infection may suffer post-COVID sequelae when returning to their training [<xref rid="B5-sports-13-00040" ref-type="bibr">5</xref>,<xref rid="B6-sports-13-00040" ref-type="bibr">6</xref>,<xref rid="B7-sports-13-00040" ref-type="bibr">7</xref>,<xref rid="B8-sports-13-00040" ref-type="bibr">8</xref>,<xref rid="B9-sports-13-00040" ref-type="bibr">9</xref>,<xref rid="B10-sports-13-00040" ref-type="bibr">10</xref>,<xref rid="B11-sports-13-00040" ref-type="bibr">11</xref>,<xref rid="B12-sports-13-00040" ref-type="bibr">12</xref>,<xref rid="B13-sports-13-00040" ref-type="bibr">13</xref>]. Indeed, the prevalence of persistent symptoms in the general population ranges from 8 to 45% [<xref rid="B14-sports-13-00040" ref-type="bibr">14</xref>], whereas in competitive athletes, it is around 1.2&#x02013;8.3% [<xref rid="B15-sports-13-00040" ref-type="bibr">15</xref>]. However, small reductions in functional exercise capacity or cognitive achievement may contribute to their reduced athletic performance [<xref rid="B16-sports-13-00040" ref-type="bibr">16</xref>]. Current recommendations for return-to-play after the SARS-CoV-2 infection course are based on the presence of symptoms, cardiac and respiratory examinations, and exercise tolerance testing [<xref rid="B17-sports-13-00040" ref-type="bibr">17</xref>].</p><p>Cardiopulmonary exercise testing (CPET) is a useful tool for assessing cardiorespiratory fitness and exercise capacity in post-COVID athletes. It evaluates aerobic and anaerobic delivery limits for adenosine triphosphate (ATP) resynthesis, involving the cardiovascular, musculoskeletal, and pulmonary systems [<xref rid="B18-sports-13-00040" ref-type="bibr">18</xref>,<xref rid="B19-sports-13-00040" ref-type="bibr">19</xref>]. The main parameter measured from CPET is maximal oxygen uptake (<inline-formula><mml:math id="mm16" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max), which reflects aerobic fitness during exercise-induced stress [<xref rid="B19-sports-13-00040" ref-type="bibr">19</xref>]. Although studies have shown that COVID-19 often presents asymptomatically or with mild symptoms in elite athletes [<xref rid="B5-sports-13-00040" ref-type="bibr">5</xref>,<xref rid="B6-sports-13-00040" ref-type="bibr">6</xref>,<xref rid="B7-sports-13-00040" ref-type="bibr">7</xref>,<xref rid="B9-sports-13-00040" ref-type="bibr">9</xref>,<xref rid="B11-sports-13-00040" ref-type="bibr">11</xref>,<xref rid="B12-sports-13-00040" ref-type="bibr">12</xref>,<xref rid="B20-sports-13-00040" ref-type="bibr">20</xref>,<xref rid="B21-sports-13-00040" ref-type="bibr">21</xref>,<xref rid="B22-sports-13-00040" ref-type="bibr">22</xref>,<xref rid="B23-sports-13-00040" ref-type="bibr">23</xref>], others have shown that post-COVID athletes have lower performance levels with reduced <inline-formula><mml:math id="mm19" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max values compared to their counterparts, despite having recovered from the disease [<xref rid="B5-sports-13-00040" ref-type="bibr">5</xref>,<xref rid="B9-sports-13-00040" ref-type="bibr">9</xref>,<xref rid="B10-sports-13-00040" ref-type="bibr">10</xref>,<xref rid="B11-sports-13-00040" ref-type="bibr">11</xref>,<xref rid="B22-sports-13-00040" ref-type="bibr">22</xref>]. Moreover, the implications of the effects of COVID-19 on the aerobic fitness of elite athletes upon return-to-play are still not well understood. Therefore, this systematic review and meta-analysis study aimed to evaluate the influence of COVID-19 on aerobic fitness in elite athletes after infection. The study was conducted with the following aims: (i) to describe the dynamics of <inline-formula><mml:math id="mm17" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max in post-COVID-19 athletes, depending on the symptoms of the disease; (ii) to assess athletic performance after 12 weeks of infection; and (iii) to discuss the pathways through which COVID-19 may influence <inline-formula><mml:math id="mm18" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max dynamics in these athletes.</p></sec><sec id="sec2-sports-13-00040"><title>2. Materials and Methods</title><sec id="sec2dot1-sports-13-00040"><title>2.1. Search Strategy</title><p>This systematic review and meta-analysis included prospective and retrospective observational studies published in the English language before 17 July 2023. The review was reported following Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guidelines and was registered, respectively, on PROSPERO (CRD42023456799). Papers were screened from the PubMed database using the following keywords: (&#x0201c;COVID-19&#x0201d; OR &#x0201c;SARS-CoV-2&#x0201d;) AND (&#x0201c;maximal oxygen uptake&#x0201d; OR &#x0201c;<inline-formula><mml:math id="mm20" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max&#x0201d; OR &#x0201c;peak VO<sub>2</sub>&#x0201d;) AND (&#x0201c;athlete&#x0201d;).</p></sec><sec id="sec2dot2-sports-13-00040"><title>2.2. Inclusion and Exclusion Criteria</title><p>The established inclusion criteria were the following: publications of reported case, cross-sectional, cohort, and case&#x02013;control studies that performed CPET for measurement of <inline-formula><mml:math id="mm21" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max in post-COVID-19 elite athletes, regardless of sport modality, whether aerobic or anaerobic. An elite athlete was defined as an individual that had one or more of the following characteristics: high VO<sub>2</sub> at the anaerobic threshold (AT) and <inline-formula><mml:math id="mm22" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max values (around 50 mL/kg/min for men and 40 mL/kg/min for women, depending on the sports category), running economy, anthropometric characteristics, participation in high-level competitions, and training characteristics (intensity, frequency, and duration) [<xref rid="B24-sports-13-00040" ref-type="bibr">24</xref>]. In addition, studies that evaluated athletes of any sport modality who had SARS-CoV-2 infection confirmed by polymerase chain reaction (PCR) or rapid antigen test and that could have asymptomatic, mild, or persistent symptoms (up to 12 weeks after infection) were also selected. Mild symptoms were defined as those who did not require hospitalization during the acute phase of the disease and without complications for more than 14 days, such as ageusia, anosmia, cough, diarrhea, fatigue, fever, headache, nasopharyngeal congestion, nausea, sore throat, and vomiting [<xref rid="B25-sports-13-00040" ref-type="bibr">25</xref>]. Papers involving intervention, lockdown, screening, face mask effect, or other contents unrelated to the infection and studies enrolling children or adolescent athletes were excluded from this review.</p></sec><sec id="sec2dot3-sports-13-00040"><title>2.3. Assessment of Risk of Bias</title><p>The information of the included studies was extracted and independently analyzed by two reviewers, based on the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE), for quality screening of cohort, case&#x02013;control, and cross-sectional studies (combined) checklist [<xref rid="B26-sports-13-00040" ref-type="bibr">26</xref>], and the score above 50% was approved for this systematic review [<xref rid="B14-sports-13-00040" ref-type="bibr">14</xref>]. In addition, a comparison of the <inline-formula><mml:math id="mm23" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max means between treadmill or cycle ergometer methods for CPET was performed using Student&#x02019;s <italic toggle="yes">t</italic>-test for independent samples to mitigate the risk of bias. Any disagreement found in the inclusion of studies and in the <inline-formula><mml:math id="mm20999" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max mean comparison analysis was resolved by a third investigator.</p></sec><sec id="sec2dot4-sports-13-00040"><title>2.4. Data Extraction and Analysis</title><p>After the selection of the suitable papers and the complete reading, the following information was synthesized: source, study type, study population (age and body mass index (BMI, Kg/m<sup>2</sup>) average, sex distribution, sport modality, and competitive level), number of post-COVID-19 and non-infected athletes, disease degree (asymptomatic, mild, or persistent symptoms), methods used for CPET (treadmill or cycle ergometer), the timing of evaluation since infection (days), <inline-formula><mml:math id="mm233333333333333333330" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max (mL/kg/min), and performed analytic comparisons in each study. These data were synthesized in an Excel spreadsheet by one reviewer and verified by two other independent reviewers.</p><p>The analyzed pooled athletes from the extracted studies were divided into two groups: post-COVID and without infection. Post-COVID-19 status was confirmed by PCR or rapid antigen test. Athletes who were uninfected and those who were infected but had information on <inline-formula><mml:math id="mm201" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max levels by CPET methods before infection were included in the infection-free group. The same athlete was included in both groups (post-COVID-19 and without infection) when the included studies compared his <inline-formula><mml:math id="mm2012" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max level before and after the infection [<xref rid="B5-sports-13-00040" ref-type="bibr">5</xref>,<xref rid="B8-sports-13-00040" ref-type="bibr">8</xref>,<xref rid="B9-sports-13-00040" ref-type="bibr">9</xref>,<xref rid="B10-sports-13-00040" ref-type="bibr">10</xref>,<xref rid="B11-sports-13-00040" ref-type="bibr">11</xref>,<xref rid="B16-sports-13-00040" ref-type="bibr">16</xref>,<xref rid="B22-sports-13-00040" ref-type="bibr">22</xref>,<xref rid="B25-sports-13-00040" ref-type="bibr">25</xref>,<xref rid="B27-sports-13-00040" ref-type="bibr">27</xref>,<xref rid="B28-sports-13-00040" ref-type="bibr">28</xref>,<xref rid="B29-sports-13-00040" ref-type="bibr">29</xref>,<xref rid="B30-sports-13-00040" ref-type="bibr">30</xref>].</p><p>Additionally, the post-COVID-19 group was stratified according to the disease&#x02019;s symptoms: asymptomatic, mild, or persistent symptoms. Persistent symptoms were defined as lasting more than 12 weeks after infection. Comparisons of means between the groups were performed using the independent Student&#x02019;s <italic toggle="yes">t</italic>-test or one-way ANOVA test with a 95% confidence interval (95% CI). For three studies that only reported the median and interquartile range (IQR), the range between the median and upper and lower bounds was found to be homogenous (presumed normal distribution), so the median was appraised as the mean. This review categorized the <inline-formula><mml:math id="mm299996" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max value (mL/kg/min) between females and males aged between 20 and 29 years, respectively, as very poor (&#x02264;30.9 and &#x02264;36.7), poor (32.3&#x02013;35.2 and 36.7&#x02013;41.0), fair (36.0&#x02013;38.5 and 41.7&#x02013;44.6), good (39.5&#x02013;42.4 and 45.4&#x02013;48.4), and excellent (&#x02265;43.9 and &#x02265;51.1), according to the Health-Related Physical Fitness Assessment Manual of the American College of Sports Medicine (ACSM) [<xref rid="B31-sports-13-00040" ref-type="bibr">31</xref>]. A linear regression was performed to assess the relationship between <inline-formula><mml:math id="mm230" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max values and BMI, and the moment of the evaluation since the infection among the subgroups. All the analyses were performed using IBM SPSS 20.0 Statistics for Windows (SPSS Inc., Chicago, IL, USA), and the level of statistical significance was defined as <italic toggle="yes">p</italic>-value &#x0003c; 0.05.</p><p>A mechanistic model of putative pathways underlying the influence of COVID-19 in <inline-formula><mml:math id="mm29" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max dynamics among elite athletes was proposed. The figure was produced with BioRender: Scientific Image and Illustration Software (<uri xlink:href="https://biorender.com/">https://biorender.com/</uri>, accessed on 18 October 2023).</p></sec></sec><sec sec-type="results" id="sec3-sports-13-00040"><title>3. Results</title><p>Of the 320 studies found in the PubMed database according to the proposed search strategy, 71 were performed with elite athletes. Among those, however, only 30 were assessed for full-text eligibility after reading the title and abstract. Finally, 27 studies were included in this systematic review, of which 21 were comparison studies and 6 were reported cases (<xref rid="sports-13-00040-f001" ref-type="fig">Figure 1</xref>). Of note, three studies were conducted with the same population [<xref rid="B25-sports-13-00040" ref-type="bibr">25</xref>,<xref rid="B29-sports-13-00040" ref-type="bibr">29</xref>,<xref rid="B30-sports-13-00040" ref-type="bibr">30</xref>] so data were only extracted from one of them. Although all the studies were performed with elite athletes, eight articles also evaluated competitive non-elite athletes [<xref rid="B6-sports-13-00040" ref-type="bibr">6</xref>,<xref rid="B7-sports-13-00040" ref-type="bibr">7</xref>,<xref rid="B25-sports-13-00040" ref-type="bibr">25</xref>,<xref rid="B27-sports-13-00040" ref-type="bibr">27</xref>,<xref rid="B29-sports-13-00040" ref-type="bibr">29</xref>,<xref rid="B30-sports-13-00040" ref-type="bibr">30</xref>,<xref rid="B32-sports-13-00040" ref-type="bibr">32</xref>], and Wernhart et al. (2023) performed a comparison between elite athletes and recreational athletes [<xref rid="B13-sports-13-00040" ref-type="bibr">13</xref>].</p><p><xref rid="sports-13-00040-t001" ref-type="table">Table 1</xref> describes the baseline information (country, study design, number of athletes, and CPET evaluation) and the methodological quality of the included studies in this systematic review. A total of 2625 athletes (1464 post-COVID-19) of the included studies performed CPET assessment via either treadmill (<italic toggle="yes">n</italic> = 11; 40.7%) or cycle ergometer (<italic toggle="yes">n</italic> = 11; 40.7%) or both (<italic toggle="yes">n</italic> = 6; (22.2%). Although the case study of Daems et al. (2022) did not report on the CPET method used to assess <inline-formula><mml:math id="mm26960" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max [<xref rid="B21-sports-13-00040" ref-type="bibr">21</xref>], it was in accordance with the established inclusion criteria. Importantly, there was no difference in the mean <inline-formula><mml:math id="mm2320" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max depending on the method used for CPET (Student&#x02019;s <italic toggle="yes">t</italic>-test, <italic toggle="yes">p</italic> = 0.33). All papers showed a percentage greater than 70% of study quality according to the STROBE checklist.</p><p>The average age of the pooled athletes was 25.7 &#x000b1; 7.3 (18&#x02013;56) years, with post-COVID-19 athletes being 5.6 &#x000b1; 2.5 years older than those without infection (Student&#x02019;s <italic toggle="yes">t</italic>-test, <italic toggle="yes">p</italic> = 0.03; 95% CI = 0.5&#x02013;10.8). The evaluated athletes were of endurance, power, mixed, or skill sports modalities. The mean CPET evaluation timing since the infection was 75.7 &#x000b1; 77.4 (2&#x02013;270) days, while the VO<sub>2</sub> at the AT was 33.8 &#x000b1; 8.4 (22&#x02013;49) mL/Kg/min. The demographic, anthropometric measures, sport modality, and oxygen consumption information of the pooled athletes are described in <xref rid="sports-13-00040-t002" ref-type="table">Table 2</xref>. In addition, the values of <inline-formula><mml:math id="mm52525" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max and <inline-formula><mml:math id="mm23690" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub> at the AT between the groups with and without COVID-19 are described in <xref rid="app1-sports-13-00040" ref-type="app">Supplementary Table S1</xref>. A total of 21 selected studies were performed with symptomatic athletes, of which 12 presented mild [<xref rid="B16-sports-13-00040" ref-type="bibr">16</xref>,<xref rid="B22-sports-13-00040" ref-type="bibr">22</xref>,<xref rid="B25-sports-13-00040" ref-type="bibr">25</xref>,<xref rid="B28-sports-13-00040" ref-type="bibr">28</xref>,<xref rid="B29-sports-13-00040" ref-type="bibr">29</xref>,<xref rid="B30-sports-13-00040" ref-type="bibr">30</xref>,<xref rid="B33-sports-13-00040" ref-type="bibr">33</xref>,<xref rid="B34-sports-13-00040" ref-type="bibr">34</xref>,<xref rid="B35-sports-13-00040" ref-type="bibr">35</xref>,<xref rid="B36-sports-13-00040" ref-type="bibr">36</xref>,<xref rid="B37-sports-13-00040" ref-type="bibr">37</xref>,<xref rid="B38-sports-13-00040" ref-type="bibr">38</xref>] and the remaining 9 with persistent symptoms [<xref rid="B8-sports-13-00040" ref-type="bibr">8</xref>,<xref rid="B9-sports-13-00040" ref-type="bibr">9</xref>,<xref rid="B10-sports-13-00040" ref-type="bibr">10</xref>,<xref rid="B11-sports-13-00040" ref-type="bibr">11</xref>,<xref rid="B12-sports-13-00040" ref-type="bibr">12</xref>,<xref rid="B13-sports-13-00040" ref-type="bibr">13</xref>,<xref rid="B16-sports-13-00040" ref-type="bibr">16</xref>]. The studies found different persistent symptoms depending on the population studied. The most common were chest pain, cough, diminished capacity and exercise-induced shortness of breath, fatigue, myalgia, palpitations, peripheral skin symptoms, and tachycardia [<xref rid="B6-sports-13-00040" ref-type="bibr">6</xref>,<xref rid="B7-sports-13-00040" ref-type="bibr">7</xref>,<xref rid="B8-sports-13-00040" ref-type="bibr">8</xref>,<xref rid="B9-sports-13-00040" ref-type="bibr">9</xref>,<xref rid="B11-sports-13-00040" ref-type="bibr">11</xref>,<xref rid="B13-sports-13-00040" ref-type="bibr">13</xref>,<xref rid="B16-sports-13-00040" ref-type="bibr">16</xref>,<xref rid="B27-sports-13-00040" ref-type="bibr">27</xref>,<xref rid="B39-sports-13-00040" ref-type="bibr">39</xref>]. Three studies were only with asymptomatic [<xref rid="B23-sports-13-00040" ref-type="bibr">23</xref>,<xref rid="B27-sports-13-00040" ref-type="bibr">27</xref>,<xref rid="B40-sports-13-00040" ref-type="bibr">40</xref>], while three evaluated asymptomatic and athletes with persistent symptoms [<xref rid="B12-sports-13-00040" ref-type="bibr">12</xref>,<xref rid="B32-sports-13-00040" ref-type="bibr">32</xref>,<xref rid="B39-sports-13-00040" ref-type="bibr">39</xref>].</p><p>Although some observational studies found no significant differences in the <inline-formula><mml:math id="mm52233" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max levels between infected and uninfected athletes [<xref rid="B5-sports-13-00040" ref-type="bibr">5</xref>,<xref rid="B6-sports-13-00040" ref-type="bibr">6</xref>,<xref rid="B7-sports-13-00040" ref-type="bibr">7</xref>,<xref rid="B28-sports-13-00040" ref-type="bibr">28</xref>,<xref rid="B37-sports-13-00040" ref-type="bibr">37</xref>,<xref rid="B38-sports-13-00040" ref-type="bibr">38</xref>,<xref rid="B39-sports-13-00040" ref-type="bibr">39</xref>,<xref rid="B40-sports-13-00040" ref-type="bibr">40</xref>], the pooled analysis showed a lower <inline-formula><mml:math id="mm5620" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max among post-COVID-19 athletes, mainly with persistent symptoms, when compared to those without infection (<italic toggle="yes">p</italic> = 0.03). Comparisons of the mean <inline-formula><mml:math id="mm419622" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max among subgroups (infection-free, asymptomatic, mild, and persistent symptoms) are shown in <xref rid="sports-13-00040-t003" ref-type="table">Table 3</xref>. There was no significant difference observed when evaluating the recovery of <inline-formula><mml:math id="mm511035" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max based on the timing of evaluation since infection (i.e., 0&#x02013;30 days, 30&#x02013;120 days, 120&#x02013;240 days, &#x0003e;240 days (<italic toggle="yes">p</italic> = 0.31)). Of the 10 studies that performed analysis of <inline-formula><mml:math id="mm525555555555555555555035" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max before and post-COVID, the mean value decreased by 6 mL/Kg/min post-infection. There was, however, no significant difference compared to CPET performed before infection. <xref rid="sports-13-00040-f002" ref-type="fig">Figure 2</xref> shows the comparison of subgroups according to fitness categories for <inline-formula><mml:math id="mm596" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max between females and males by age [<xref rid="B31-sports-13-00040" ref-type="bibr">31</xref>]. Athletes who had mild or persistent symptoms had a lower <inline-formula><mml:math id="mm75" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max than those without infection (Tukey test, <italic toggle="yes">p</italic> = 0.02). Nevertheless, according to the ACSM, the <inline-formula><mml:math id="mm635" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max value post-COVID-19 did not reach the very poor threshold (&#x0003c;15%), considering the age of 20 to 29 years for males (36.7 mL/Kg/min) and females (30.9 mL/Kg/min). It should be highlighted that approximately 70% of the sample studied in the observational studies included in this systematic review were males, except for the studies by Nedeljkovic et al. (2021) and Stojmenovic et al. (2023), who did not report the sex distribution of the evaluated athletes [<xref rid="B8-sports-13-00040" ref-type="bibr">8</xref>,<xref rid="B23-sports-13-00040" ref-type="bibr">23</xref>].</p><table-wrap position="anchor" id="sports-13-00040-t001"><object-id pub-id-type="pii">sports-13-00040-t001_Table 1</object-id><label>Table 1</label><caption><p>Summary of observational studies that included cardiopulmonary exercise testing (CPET) post-COVID-19 in elite athletes.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Source</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Origins</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Study Design</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">N&#x000ba; Infected/All Athletes</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">CPET Evaluation</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Primary Analytic Comparisons</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Quality Score (%) <sup>a</sup></th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anastasio et al., 2021 [<xref rid="B40-sports-13-00040" ref-type="bibr">40</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Italy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case&#x02013;control study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13/26</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treadmill</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Athletes recovered from mild&#x02013;moderate COVID-19 were matched with elite cross-country skiers without SARS-CoV-2 infection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Babity et al., 2022 [<xref rid="B27-sports-13-00040" ref-type="bibr">27</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hungary</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cross-sectional study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">183/183</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treadmill</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPET comparisons were performed in 62 asymptomatic elite athletes between examination before and after the SARS-CoV-2 infection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">82.8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Barker-Davies et al., 2023 [<xref rid="B5-sports-13-00040" ref-type="bibr">5</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">United Kingdom</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1/1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cycle ergometer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPET comparisons between 15 months prior and 5 months post-COVID-19 diagnosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA <sup>b</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brito et al., 2023 [<xref rid="B39-sports-13-00040" ref-type="bibr">39</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brazil</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cross-sectional study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">46/46</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treadmill</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPET comparisons between symptomatic and asymptomatic after the SARS-CoV-2 infection in all study participants</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">82.8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brown et al., 2022 [<xref rid="B16-sports-13-00040" ref-type="bibr">16</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">USA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1/1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cycle ergometer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPET comparisons between 6 days before and 19 weeks after COVID-19 diagnosis</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA <sup>b</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cavigli et al., 2021 [<xref rid="B32-sports-13-00040" ref-type="bibr">32</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Italy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90/90</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cycle ergometer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPET comparison between asymptomatic vs. symptomatic individuals</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Csulak et al., 2021 [<xref rid="B28-sports-13-00040" ref-type="bibr">28</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hungary</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14/46</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treadmill</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPET comparisons between infected and non-infected swimmers on pre- and post-COVID-19 pandemic</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Daems et al., 2022 [<xref rid="B21-sports-13-00040" ref-type="bibr">21</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Netherlands</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1/1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Descriptive</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA <sup>b</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fikenzer et al., 2021 [<xref rid="B22-sports-13-00040" ref-type="bibr">22</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Germany</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cross-sectional study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8/12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cycle ergometer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPET comparisons between the summer 2020 (t0) preparation phase and either after SARS-CoV-2 infection in winter 2020 or during routine control in winter 2020 (t1).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Keller et al., 2023 [<xref rid="B33-sports-13-00040" ref-type="bibr">33</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Germany</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cross-sectional study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">157/1200</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treadmill or cycle ergometer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPET comparisons of athletes with and without former COVID-19 infection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">82.8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Komici et al., 2021 [<xref rid="B6-sports-13-00040" ref-type="bibr">6</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Italy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case&#x02013;control study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24/35</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treadmill</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPET comparisons of COVID-19 athletes and a group of competitive athletes following previous physical capacity evaluation after summer holidays and before starting training program tested negative for COVID-19</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Maestrini et al., 2023 [<xref rid="B34-sports-13-00040" ref-type="bibr">34</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Italy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cross-sectional study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">219/219</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cycle ergometer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Descriptive</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">76.7</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Maestrini et al., 2022 [<xref rid="B35-sports-13-00040" ref-type="bibr">35</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Italy</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cross-sectional study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">47/47</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cycle ergometer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Descriptive</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">82.8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Milovancev et al., 2021 [<xref rid="B36-sports-13-00040" ref-type="bibr">36</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Serbia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cross-sectional study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16/16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treadmill</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Descriptive</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mitrani et al., 2021 [<xref rid="B37-sports-13-00040" ref-type="bibr">37</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">USA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cross-sectional study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">174/174</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treadmill</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Descriptive</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moulson et al., 2022 [<xref rid="B7-sports-13-00040" ref-type="bibr">7</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">USA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective cohort study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21/63</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treadmill</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Post-COVID athletes were compared with a matched reference group of healthy athletes without COVID-19 infection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">83.9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nedeljkovic et al., 2021 [<xref rid="B8-sports-13-00040" ref-type="bibr">8</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Serbia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1/1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treadmill</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPET comparisons between 2-week and 3-month follow-up after infection with testing performed before infection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA <sup>b</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Parpa et al., 2022 [<xref rid="B9-sports-13-00040" ref-type="bibr">9</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cyprus</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cross-sectional study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21/21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cycle ergometer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPET comparisons between the same athletes before and after SARS-CoV-2 infection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">72.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rao et al., 2022 [<xref rid="B10-sports-13-00040" ref-type="bibr">10</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">USA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1/1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cycle ergometer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPET comparisons between before and after SARS-CoV-2 infection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA <sup>b</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rudofker et al., 2022 [<xref rid="B11-sports-13-00040" ref-type="bibr">11</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">USA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Case study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1/1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cycle ergometer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Descriptive</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA <sup>b</sup></td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0015a;li&#x0017c; et al., 2022 [<xref rid="B25-sports-13-00040" ref-type="bibr">25</xref>]; &#x0015a;li&#x0017c; et al., 2022 [<xref rid="B29-sports-13-00040" ref-type="bibr">29</xref>]; &#x0015a;li&#x0017c; et al., 2023 [<xref rid="B30-sports-13-00040" ref-type="bibr">30</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Poland</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cross-sectional study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">49/49</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treadmill or cycle ergometer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPET comparisons between before and after SARS-CoV-2 infection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">82.8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stavrou et al., 2023 [<xref rid="B38-sports-13-00040" ref-type="bibr">38</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Greece</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cross-sectional study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20/40</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treadmill</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPET comparisons between previously infected with SARS-CoV-2 versus non-infected athletes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stojmenovic et al., 2023 [<xref rid="B23-sports-13-00040" ref-type="bibr">23</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Serbia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">220/220</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Treadmill</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPET comparisons among the three strains of the SARS-CoV-2 (Wuhan, Delta, or Omicron)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">75.9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vollrath et al., 2022 [<xref rid="B12-sports-13-00040" ref-type="bibr">12</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Germany</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Prospective study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60/60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cycle ergometer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPET comparisons between t0 (4.1 &#x000b1; 3.8 months after infection) and t1 three months later (3.3 &#x000b1; 0.5 months)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">79.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wernhart et al., 2023 [<xref rid="B13-sports-13-00040" ref-type="bibr">13</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Germany</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cross-sectional study</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">83/83</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cycle ergometer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CPET comparisons between elite and recreational athletes who reported persistent symptoms of COVID-19 infection</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">82.8</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> The score was based on the STROBE checklist of cohort, case&#x02013;control, and cross-sectional studies (combined). <sup>b</sup> Reported case studies that do not have STROBE assessment; however, they were included in this systematic review because they were considered relevant. NA, not applicable.</p></fn></table-wrap-foot></table-wrap><table-wrap position="anchor" id="sports-13-00040-t002"><object-id pub-id-type="pii">sports-13-00040-t002_Table 2</object-id><label>Table 2</label><caption><p>Sample characteristics and oxygen consumption post-COVID-19 observed in each study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Source</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Age (Years) <sup>a</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Male Sex <break/>N (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">BMI (Kg/m<sup>2</sup>) <sup>a</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Sport Modality</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Timing of Evaluation Since Infection (Days) <sup>a,b</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><inline-formula><mml:math id="mm599925" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="bold">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max Post-Infection (mL/kg/min) <sup>a</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">VO<sub>2</sub> at AT Post-Infection (mL/kg/min) <sup>a,d</sup></th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Anastasio et al., 2021 [<xref rid="B40-sports-13-00040" ref-type="bibr">40</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases: 21 &#x000b1; 5<break/>Controls: 20 &#x000b1; 4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases: 10 (77)<break/>Controls: 8 (62)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases: 22 &#x000b1; 2<break/>Controls: 21 &#x000b1; 1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cross-country skiing</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28&#x02013;42</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56.9 (48.5&#x02013;64.3)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.8 (43.5&#x02013;56.0)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Babity et al., 2022 [<xref rid="B27-sports-13-00040" ref-type="bibr">27</xref>] <sup>c</sup></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20 (17&#x02013;24)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">122 (74)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Basketball; ice hockey; water polo; wrestling; swimming; running; football; handball; others</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">94 (67&#x02013;130)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50.9 &#x000b1; 6.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44.2 &#x000b1; 5.0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Barker-Davies et al., 2023 [<xref rid="B5-sports-13-00040" ref-type="bibr">5</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (100)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Distance running</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">59</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27.0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brito et al., 2023 [<xref rid="B39-sports-13-00040" ref-type="bibr">39</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30 &#x000b1; 9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26 (57)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26 &#x000b1; 5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Soccer; CrossFit; rugby; athletics; para athletic; combat sports; swimming; volleyball; rowing; others</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14&#x02013;252</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41.1 &#x000b1; 8.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.5 &#x000b1; 6.2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brown et al., 2022 [<xref rid="B16-sports-13-00040" ref-type="bibr">16</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (100)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">133</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">38.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cavigli et al., 2021 [<xref rid="B32-sports-13-00040" ref-type="bibr">32</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 &#x000b1; 10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">64 (71)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23 &#x000b1; 3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Endurance; mixed; power; skill</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39.0 &#x000b1; 6.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Csulak et al., 2021 [<xref rid="B28-sports-13-00040" ref-type="bibr">28</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases: 23 &#x000b1; 4<break/>Non-infected: 24 &#x000b1; 4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases: 7 (50)<break/>Non-infected: 18 (56)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Swimming</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10&#x02013;14</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Female: 52.9 &#x000b1; 4.1<break/>Male: 56.5 &#x000b1; 4.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Daems et al., 2022 [<xref rid="B21-sports-13-00040" ref-type="bibr">21</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (100)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Soccer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">270</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fikenzer et al., 2021 [<xref rid="B22-sports-13-00040" ref-type="bibr">22</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases: 27 &#x000b1; 4<break/>Non-infected: 22 &#x000b1; 3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">12 (100)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases: ~27 (97 kg; 191 cm)<break/>Non-infected: ~26 (96 kg; 194 cm)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Handball</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases: ~39.2 (3790 &#x000b1; 513 mL/min; 96.7 &#x000b1; 5.4 kg)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Keller et al., 2023 [<xref rid="B33-sports-13-00040" ref-type="bibr">33</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases: 23 &#x000b1; 7Non-infected: 22 &#x000b1; 12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases: 122 (78)<break/>Controls: 667 (64)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases: 24 (22&#x02013;26)<break/>Non-infected: 22 (20&#x02013;24)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Several</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">43.4 (38.3&#x02013;48.0)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Komici et al., 2021 [<xref rid="B6-sports-13-00040" ref-type="bibr">6</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases: 24 (20&#x02013;26)<break/>Non-infected: 21 (10&#x02013;24)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35 (100)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases: 23 (22&#x02013;24)<break/>Non-infected: 23 (22&#x02013;26)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Soccer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10&#x02013;30</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50.1 (47.7&#x02013;51.6)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Maestrini et al., 2023 [<xref rid="B34-sports-13-00040" ref-type="bibr">34</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23 (19&#x02013;27)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">129 (59)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23 (22&#x02013;25)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Endurance; mixed<break/>power; skill</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">10 (6&#x02013;17)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">39 &#x000b1; 8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Maestrini et al., 2022 [<xref rid="B35-sports-13-00040" ref-type="bibr">35</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">26 &#x000b1; 4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32 (68)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 &#x000b1; 3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Endurance; power; mixed</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9 (6&#x02013;13)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">42 &#x000b1; 6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22 &#x000b1; 4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Milovancev et al., 2021 [<xref rid="B36-sports-13-00040" ref-type="bibr">36</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 &#x000b1; 5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">16 (100)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 &#x000b1; 2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Volleyball</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">20 &#x000b1; 5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44.1 &#x000b1; 3.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40.8 &#x000b1; 3.9</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Mitrani et al., 2021 [<xref rid="B37-sports-13-00040" ref-type="bibr">37</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21 (19&#x02013;22)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">122 (70)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Baseball; football; basketball; volleyball; soccer; swimming; others</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">19 (16&#x02013;25)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">37.7 &#x000b1; 8.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Moulson et al., 2022 [<xref rid="B7-sports-13-00040" ref-type="bibr">7</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases: 22 &#x000b1; 4<break/>Non-infected: 22 &#x000b1; 4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases: 12 (57)<break/><break/>Non-infected: 24 (51)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases: 23 &#x000b1; 3<break/>Non-infected: 24 &#x000b1; 3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Endurance; team sport; mixed</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">90 &#x000b1; 60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">44.6 &#x000b1; 9.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35.7 &#x000b1; 11.3</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nedeljkovic et al., 2021 [<xref rid="B8-sports-13-00040" ref-type="bibr">8</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">23.1</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Parpa et al., 2022 [<xref rid="B9-sports-13-00040" ref-type="bibr">9</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 &#x000b1; 6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">21 (100)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">~23 (74 &#x000b1; 5 kg; 178 &#x000b1; 5 cm)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Soccer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">54.3 &#x000b1; 5.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">36.9 &#x000b1; 5.2</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rao et al., 2022 [<xref rid="B10-sports-13-00040" ref-type="bibr">10</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (100)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rowing</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Rudofker et al., 2022 [<xref rid="B11-sports-13-00040" ref-type="bibr">11</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">56</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1 (100)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">270</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0015a;li&#x0017c; et al., 2022 [<xref rid="B25-sports-13-00040" ref-type="bibr">25</xref>]; &#x0015a;li&#x0017c; et al., 2022 [<xref rid="B29-sports-13-00040" ref-type="bibr">29</xref>]; &#x0015a;li&#x0017c; et al., 2023 [<xref rid="B30-sports-13-00040" ref-type="bibr">30</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">40 &#x000b1; 8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">43 (88)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 &#x000b1; 3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Endurance</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">155 &#x000b1; 82</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">45 &#x000b1; 7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">32 &#x000b1; 6</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stavrou et al., 2023 [<xref rid="B38-sports-13-00040" ref-type="bibr">38</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases: 25 &#x000b1; 4<break/>Non-infected: 25 &#x000b1; 4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases: 20 (100)<break/>Non-infected: 20 (100)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cases: 23 &#x000b1; 2<break/>Non-infected: 24 &#x000b1; 1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Soccer</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55.7 &#x000b1; 4.4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Stojmenovic et al., 2023 [<xref rid="B23-sports-13-00040" ref-type="bibr">23</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Soccer: 23 &#x000b1; 5<break/>Basketball: 25 &#x000b1; 5</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Soccer; basketball</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">22</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wuhan: 47.6 &#x000b1; 5.1 Delta: 47.9 &#x000b1; 4.6 Omicron: 50.6 &#x000b1; 4.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wuhan: 26.2 &#x000b1; 4.7 Delta: 24.9 &#x000b1; 3.7 Omicron: 30.4 &#x000b1; 4.4</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vollrath et al., 2022 [<xref rid="B12-sports-13-00040" ref-type="bibr">12</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">35 &#x000b1; 12</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34 (57)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">24 &#x000b1; 4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Several</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">120 &#x000b1; 90</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">t0:<break/>Symptoms free: 44.7 &#x000b1; 7.7 Persistent symptoms: 33.7&#x000b1;9.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Wernhart et al., 2023 [<xref rid="B13-sports-13-00040" ref-type="bibr">13</xref>]</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Elite: 22 &#x000b1; 4 Recreational: 35 &#x000b1; 13</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Elite: 29 (67)<break/>Recreational: 21 (53)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Elite: 24 &#x000b1; 2<break/> Recreational: 24 &#x000b1; 4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Football; handball; endurance; badminton; swimming</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">180</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Elite: 44.8 &#x000b1; 6.8</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">No information</td></tr></tbody></table><table-wrap-foot><fn><p>Mixed corresponds to the sports whose participants are not of a single sex. Several correspond to different sports. <sup>a</sup> The values were presented as absolute value, mean &#x000b1; standard deviation, median (IQR), or range. <sup>b</sup> One week was considered with 7 days, while one month with 30 days. <sup>c</sup> Information obtained from 165 asymptomatic athletes. <sup>d</sup> VO<sub>2</sub> at AT post-infection = oxygen uptake at the AT after the COVID-19 infection. AT, anaerobic threshold; BMI, body mass index; NA, not applicable; <inline-formula><mml:math id="mm522525" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max, maximal oxygen uptake.</p></fn></table-wrap-foot></table-wrap><table-wrap position="anchor" id="sports-13-00040-t003"><object-id pub-id-type="pii">sports-13-00040-t003_Table 3</object-id><label>Table 3</label><caption><p>Comparison of the mean <inline-formula><mml:math id="mm55522525" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max between post-COVID-19 and infection-free, as well as asymptomatic and symptomatic athletes of all included studies.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Comparisons</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mean &#x000b1; SD</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>-Value <sup>a</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Post Hoc Test (Tukey HRD)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mean Difference <break/>(95% CI)</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Without infection</td><td align="center" valign="middle" rowspan="1" colspan="1">49.54 &#x000b1; 8.56</td><td rowspan="2" align="center" valign="middle" colspan="1">0.03</td><td rowspan="2" align="center" valign="middle" colspan="1">---</td><td align="center" valign="middle" rowspan="1" colspan="1">1 <sup>b</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Post-infection</td><td align="center" valign="middle" rowspan="1" colspan="1">43.90 &#x000b1; 7.92</td><td align="center" valign="middle" rowspan="1" colspan="1">5.64 (0.52&#x02013;10.76)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Without infection</td><td align="center" valign="middle" rowspan="1" colspan="1">49.54 &#x000b1; 8.56</td><td rowspan="4" align="center" valign="middle" colspan="1">0.06</td><td align="center" valign="middle" rowspan="1" colspan="1">1 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1 <sup>b</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Asymptomatic</td><td align="center" valign="middle" rowspan="1" colspan="1">50.29 &#x000b1; 5.11</td><td align="center" valign="middle" rowspan="1" colspan="1">0.99</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;0.75 (&#x02212;13.01&#x02013;11.51)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Mild symptoms</td><td align="center" valign="middle" rowspan="1" colspan="1">43.70 &#x000b1; 6.11</td><td align="center" valign="middle" rowspan="1" colspan="1">0.27</td><td align="center" valign="middle" rowspan="1" colspan="1">5.84 (&#x02212;2.74&#x02013;14.44)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Persistent symptoms</td><td align="center" valign="middle" rowspan="1" colspan="1">41.55 &#x000b1; 9.79</td><td align="center" valign="middle" rowspan="1" colspan="1">0.07</td><td align="center" valign="middle" rowspan="1" colspan="1">8.00 (&#x02212;0.38&#x02013;16.37)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Without infection</td><td align="center" valign="middle" rowspan="1" colspan="1">49.54 &#x000b1; 8.56</td><td rowspan="3" align="center" valign="middle" colspan="1">0.05</td><td align="center" valign="middle" rowspan="1" colspan="1">1 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1 <sup>b</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Asymptomatic or Mild symptoms</td><td align="center" valign="middle" rowspan="1" colspan="1">45.45 &#x000b1; 6.43</td><td align="center" valign="middle" rowspan="1" colspan="1">0.36</td><td align="center" valign="middle" rowspan="1" colspan="1">4.09 (&#x02212;3.14&#x02013;11.32)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Persistent symptoms</td><td align="center" valign="middle" rowspan="1" colspan="1">41.55 &#x000b1; 9.79</td><td align="center" valign="middle" rowspan="1" colspan="1">0.04</td><td align="center" valign="middle" rowspan="1" colspan="1">7.99 (0.31&#x02013;15.68)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Without infection</td><td align="center" valign="middle" rowspan="1" colspan="1">49.54 &#x000b1; 8.56</td><td rowspan="3" align="center" valign="middle" colspan="1">0.02</td><td align="center" valign="middle" rowspan="1" colspan="1">1 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1 <sup>b</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Asymptomatic </td><td align="center" valign="middle" rowspan="1" colspan="1">50.29 &#x000b1; 5.11</td><td align="center" valign="middle" rowspan="1" colspan="1">0.98</td><td align="center" valign="middle" rowspan="1" colspan="1">0.75 (&#x02212;11.79&#x02013;10.29)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Symptomatic</td><td align="center" valign="middle" rowspan="1" colspan="1">42.57 &#x000b1; 8.13</td><td align="center" valign="middle" rowspan="1" colspan="1">0.03</td><td align="center" valign="middle" rowspan="1" colspan="1">6.97 (0.54&#x02013;13.39)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Asymptomatic </td><td align="center" valign="middle" rowspan="1" colspan="1">50.29 &#x000b1; 5.11</td><td rowspan="2" align="center" valign="middle" colspan="1">0.08</td><td rowspan="2" align="center" valign="middle" colspan="1">----</td><td align="center" valign="middle" rowspan="1" colspan="1">1 <sup>b</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Symptomatic</td><td align="center" valign="middle" rowspan="1" colspan="1">42.57 &#x000b1; 8.13</td><td align="center" valign="middle" rowspan="1" colspan="1">7.71 (&#x02212;1.02&#x02013;16.45)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Asymptomatic</td><td align="center" valign="middle" rowspan="1" colspan="1">50.29 &#x000b1; 5.11</td><td rowspan="3" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">0.18</td><td align="center" valign="middle" rowspan="1" colspan="1">1 <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1 <sup>b</sup></td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Mild symptoms</td><td align="center" valign="middle" rowspan="1" colspan="1">43.70 &#x000b1; 6.11</td><td align="center" valign="middle" rowspan="1" colspan="1">0.34</td><td align="center" valign="middle" rowspan="1" colspan="1">6.60 (&#x02212;4.96&#x02013;18.15)</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Persistent symptoms</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41.55 &#x000b1; 9.79</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.16</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.75 (&#x02212;2.68&#x02013;20.17)</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup>&#x000a0;<italic toggle="yes">p</italic>-value was obtained by Student&#x02019;s <italic toggle="yes">t</italic>-test or one-way ANOVA. <sup>b</sup> Reference value. CI, confidence interval; SD, standard deviation.</p></fn></table-wrap-foot></table-wrap><p>There was no significant difference in BMI between the post-COVID-19 and infection-free athletes (23.8 &#x000b1; 1.1 Kg/m<sup>2</sup> versus 23.4 &#x000b1; 1.4 Kg/m<sup>2</sup>, respectively). However, the <inline-formula><mml:math id="mm451" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max and BMI were inversely correlated. For each increase of 1 Kg/m<sup>2</sup> in BMI, the mean <inline-formula><mml:math id="mm41852" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max significantly decreased by 2.9 mL/Kg/min in the post-infected subgroup (one-way ANOVA test, <italic toggle="yes">p</italic> = 0.04), while there was no difference in athletes without infection. Moreover, residual analysis of the linear regression model showed normal distribution and homoscedasticity between <inline-formula><mml:math id="mm4184" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max post-COVID-19 of the athletes who performed CPET above 12 weeks and independent variables (age and BMI). Thus, BMI contributed five times more than age to lower <inline-formula><mml:math id="mm4162" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max (&#x003b2;: &#x02212;1.0; 95% CI: &#x02212;2.7&#x02013;&#x02212;1.6 versus &#x003b2;: 0.2; 95% CI: 0.1&#x02013;1.1, respectively) in athletes who performed CPET after 12 weeks post-COVID-19. In contrast, there was no correlation among those who rated the 12-week mark (<xref rid="sports-13-00040-f003" ref-type="fig">Figure 3</xref>).</p><p>Based on these findings and the biological importance of the effect of <inline-formula><mml:math id="mm641" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max dynamics has in elite athletes, we hypothesized a possible relationship between the COVID-19 disease and athlete performance (<xref rid="sports-13-00040-f004" ref-type="fig">Figure 4</xref>).</p></sec><sec sec-type="discussion" id="sec4-sports-13-00040"><title>4. Discussion</title><p>In this systematic review and meta-analysis study, a total of 27 observational studies performed CPET on 1464 post-COVID-19 athletes, including approximately 570 with mild symptoms and 400 with persistent symptoms up to 12 weeks after infection. Vollrath et al. (2022) observed the presence of persistent symptoms in 73.3% of the 60 athletes evaluated four months after infection, and in 62% at three months later [<xref rid="B12-sports-13-00040" ref-type="bibr">12</xref>]. In addition, a 21-year-old male football player, with mild symptoms during infection, began experiencing palpitations one day after returning to training and persisted for one month. Following cardiac magnetic resonance imaging, he was diagnosed with focal COVID-19 myocarditis [<xref rid="B21-sports-13-00040" ref-type="bibr">21</xref>].</p><p>Physical fitness reduces the severity of upper respiratory tract infections [<xref rid="B41-sports-13-00040" ref-type="bibr">41</xref>]. However, SARS-CoV-2 infection impairs lymphopoiesis [<xref rid="B42-sports-13-00040" ref-type="bibr">42</xref>], which may contribute to a more severe disease course in high-performance athletes. A cross-sectional study conducted prior to vaccination found that 26% of athletes who did not undergo diagnostic testing for COVID-19 reported at least three mild symptoms of the illness during the lockdown, while only 11% of those infected were asymptomatic and 1.5% were hospitalized for illness [<xref rid="B43-sports-13-00040" ref-type="bibr">43</xref>], making the return to practice after infection a concern. A challenge for sports medicine is to differentiate between cardiopulmonary disease and common flu-like symptoms after vigorous exercise in elite athletes [<xref rid="B5-sports-13-00040" ref-type="bibr">5</xref>,<xref rid="B44-sports-13-00040" ref-type="bibr">44</xref>]. In endurance athletes, the immune system can be suppressed within 12 h of high-intensity exercise or for 2 weeks after a marathon race [<xref rid="B45-sports-13-00040" ref-type="bibr">45</xref>]. In addition, exercise alters the number of circulating lymphocytes and the release of cortisol, which affects the expression and function of anti-inflammatory cytokines [<xref rid="B46-sports-13-00040" ref-type="bibr">46</xref>]. Myocarditis is one of the main complications of viral syndromes, and COVID-19 may increase the incidence of this cardiac injury [<xref rid="B17-sports-13-00040" ref-type="bibr">17</xref>,<xref rid="B47-sports-13-00040" ref-type="bibr">47</xref>]. COVID-19 causes a more severe and prolonged reduction in <inline-formula><mml:math id="mm5110999999999999999999995" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max, particularly when persistent symptoms are present. Mitrani and colleagues (2022) observed an incidence of post-COVID-19 myocardial involvement of 2.9%, detected around 18.5 days after a positive COVID-19 PCR diagnosis among highly trained athletes, even with normal <inline-formula><mml:math id="mm5110535" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max [<xref rid="B37-sports-13-00040" ref-type="bibr">37</xref>].</p><p>A study by Hull et al. (2022) found that athletes with COVID-19 experienced a median symptom duration of 10 days and training loss ranging from 12 to 30 days, significantly exceeding the 6 (0&#x02013;7) days of training loss associated with non-COVID-19 respiratory illnesses [<xref rid="B48-sports-13-00040" ref-type="bibr">48</xref>]. Exercise intolerance has been frequently reported as a post-COVID sequelae, especially in individuals hospitalized during the acute infection period [<xref rid="B49-sports-13-00040" ref-type="bibr">49</xref>]. Although the frequency of hospitalization for COVID-19 in athletes is less than 2% [<xref rid="B50-sports-13-00040" ref-type="bibr">50</xref>], our analysis of the pooled studies showed lower cardiorespiratory fitness in post-COVID-19 athletes compared to infection-free athletes, and those with persistent symptoms exhibited lower <inline-formula><mml:math id="mm5110385" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max levels. This suggests that even elite athletes, who typically have a higher aerobic capacity compared to sedentary individuals, may experience significant respiratory and muscular strain during exercise [<xref rid="B38-sports-13-00040" ref-type="bibr">38</xref>], leading to performance limitations. Studies have demonstrated that SARS-CoV-2 infection reduced the <inline-formula><mml:math id="mm51189035" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max levels and anaerobic threshold, resulting in increased respiratory work during exercise [<xref rid="B38-sports-13-00040" ref-type="bibr">38</xref>,<xref rid="B40-sports-13-00040" ref-type="bibr">40</xref>,<xref rid="B49-sports-13-00040" ref-type="bibr">49</xref>]. An elite long-distance runner with a reduction in anaerobic transition showed a 27 W decrease in workload and a 13% decrease in oxygen uptake, representing a significant loss in aerobic capacity [<xref rid="B5-sports-13-00040" ref-type="bibr">5</xref>]. In addition, a meta-analysis conducted by Durstenfeld and colleagues (2022) found a difference of approximately 5 mL/kg/min less in adult athletes and non-athletes with persistent symptoms compared to recovered individuals. However, 53% were hospitalized patients with an average age of 50 years [<xref rid="B51-sports-13-00040" ref-type="bibr">51</xref>]. Existing evidence indicates that <inline-formula><mml:math id="mm4112" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max levels oscillate according to age, increasing up to the 40&#x02013;49 age group and decreasing in older individual non-athletes (&#x0003e;50 years) [<xref rid="B52-sports-13-00040" ref-type="bibr">52</xref>]. Although elite athletes are younger, starting their sporting career at around 10 years old and retiring at 30 [<xref rid="B53-sports-13-00040" ref-type="bibr">53</xref>], athletes under 27 years old were associated with a three-fold higher risk of infection [<xref rid="B43-sports-13-00040" ref-type="bibr">43</xref>].</p><p>High-intensity training can improve <inline-formula><mml:math id="mm4152" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max by up to 15% in elite athletes [<xref rid="B54-sports-13-00040" ref-type="bibr">54</xref>]. Even with different training protocols (e.g., high-intensity interval training, functional training) and differences in the dynamics of sport modalities (e.g., endurance, power, skill), cardiorespiratory fitness is significantly higher in elite athletes compared with non-elite athletes [<xref rid="B55-sports-13-00040" ref-type="bibr">55</xref>] and non-athletes [<xref rid="B56-sports-13-00040" ref-type="bibr">56</xref>]. Wernhart and colleagues (2023) analyzed the cardiopulmonary profile of elite and recreational athletes with post-exercise malaise after COVID-19 infection. They found that the recreational athletes had a <inline-formula><mml:math id="mm855" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max level of 12 mL/kg/min lower compared to their counterparts. In addition, 70% of recreational athletes had an inadequate cardiopulmonary response, compared to 40% of elite athletes [<xref rid="B13-sports-13-00040" ref-type="bibr">13</xref>]. In this systematic review, most of the analyzed pooled athletes were males aged 20&#x02013;29 years old, and the average <inline-formula><mml:math id="mm9655" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max in those with persistent symptoms was around 42 mL/kg/min, not reaching the poor grade (&#x0003c;35% aerobic fitness), according to ACSM for this category [<xref rid="B31-sports-13-00040" ref-type="bibr">31</xref>]. This may explain why elite athletes had fewer hospitalizations and required mechanical ventilation.</p><p>Well-known risk factors for infection and disease severity included age, male sex, obesity, and comorbidities [<xref rid="B43-sports-13-00040" ref-type="bibr">43</xref>,<xref rid="B57-sports-13-00040" ref-type="bibr">57</xref>]. The virus enters host cells by binding its spike protein (S) with the angiotensin-converting enzyme 2 (ACE2), one of the main enzymes of the renin&#x02013;angiotensin system (RAS). This receptor is expressed in the cell membrane of the oral mucosa, respiratory tract, heart cells, adipocytes, and muscle [<xref rid="B58-sports-13-00040" ref-type="bibr">58</xref>]. Functionally, ACE2 is responsible for the hydrolysis of angiotensin II into angiotensin 1&#x02013;7, which increases vasodilation, and produces anti-inflammatory, antioxidant, and anti-fibrosis effects [<xref rid="B59-sports-13-00040" ref-type="bibr">59</xref>]. The viral protein spike downregulates ACE2, causing vasoconstriction, increasing the inflammatory response [<xref rid="B60-sports-13-00040" ref-type="bibr">60</xref>], and decreasing the <inline-formula><mml:math id="mm45632" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max value in athletes [<xref rid="B5-sports-13-00040" ref-type="bibr">5</xref>,<xref rid="B9-sports-13-00040" ref-type="bibr">9</xref>,<xref rid="B10-sports-13-00040" ref-type="bibr">10</xref>,<xref rid="B11-sports-13-00040" ref-type="bibr">11</xref>,<xref rid="B16-sports-13-00040" ref-type="bibr">16</xref>,<xref rid="B22-sports-13-00040" ref-type="bibr">22</xref>]. The expression of the ACE2 gene is reported to be positively correlated with increased BMI in COVID-19 subjects. Specifically, ACE2 overexpression is observed in individuals with a BMI of more than 30 kg/m<sup>2</sup> [<xref rid="B61-sports-13-00040" ref-type="bibr">61</xref>]. Our pooled analysis of the athletes revealed a decrease of almost 3 mL/Kg/min in <inline-formula><mml:math id="mm41" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max levels after the acute course of COVID-19 and of 1 mL/kg/min 12 weeks later according to the increase in the BMI. The athlete&#x02019;s fast recovery after COVID-19 can be explained by the rehabilitation medicine protocol during the return to training, which can reestablish <inline-formula><mml:math id="mm412" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max as before the infection [<xref rid="B5-sports-13-00040" ref-type="bibr">5</xref>,<xref rid="B11-sports-13-00040" ref-type="bibr">11</xref>,<xref rid="B21-sports-13-00040" ref-type="bibr">21</xref>,<xref rid="B27-sports-13-00040" ref-type="bibr">27</xref>]. However, a higher ACE2 expression might contribute to lower <inline-formula><mml:math id="mm320" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max levels in athletes with persistent symptoms.</p><p>Based on the findings, we propose a hypothesis of how COVID-19 disease may influence the vasoconstriction/vasodilation imbalance and affect <inline-formula><mml:math id="mm920" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max dynamics in elite athletes (<xref rid="sports-13-00040-f004" ref-type="fig">Figure 4</xref>). Briefly, high-intensity exercise interacts with RAS, inducing a downregulation of the angiotensin-converting enzyme (ACE) and upregulation of ACE2, which causes vasodilation [<xref rid="B58-sports-13-00040" ref-type="bibr">58</xref>,<xref rid="B60-sports-13-00040" ref-type="bibr">60</xref>], and improves the <inline-formula><mml:math id="mm2963333333333333333330" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max [<xref rid="B60-sports-13-00040" ref-type="bibr">60</xref>]. Recent studies have shown that genetic variants can influence <inline-formula><mml:math id="mm23330" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max dynamics and aerobics [<xref rid="B20-sports-13-00040" ref-type="bibr">20</xref>,<xref rid="B60-sports-13-00040" ref-type="bibr">60</xref>]. Thus, single-nucleotide polymorphisms (SNPs) in combination with environmental factors (e.g., exercise capacity and exercise intensity) may modulate the <inline-formula><mml:math id="mm51103599" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max phenotype and contribute to oxygen delivery [<xref rid="B62-sports-13-00040" ref-type="bibr">62</xref>]. The genetic influence on <inline-formula><mml:math id="mm22690" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max is still not fully understood; however, the <italic toggle="yes">ACE</italic> gene has been associated with higher <inline-formula><mml:math id="mm1520" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max levels and better endurance performance in well-trained athletes [<xref rid="B63-sports-13-00040" ref-type="bibr">63</xref>]. Furthermore, SNPs on <italic toggle="yes">ACE</italic> and <italic toggle="yes">ACE2</italic> genes were associated with musculoskeletal injuries in athletes [<xref rid="B64-sports-13-00040" ref-type="bibr">64</xref>], and recently with infection and the severity of COVID-19 in the general population [<xref rid="B65-sports-13-00040" ref-type="bibr">65</xref>]. For example, genetic variants in specific targets, such as ACE and ACE2 SNPs, may impair the performance and muscular endurance of athletes and affect their return-to-play performance after COVID-19, which may also negatively affect their mental health. The absence of training during the COVID-19 pandemic has already been associated with the risk (~three-fold) of depression in athletes [<xref rid="B66-sports-13-00040" ref-type="bibr">66</xref>], demonstrating that time away from games and championships can affect their quality of life and well-being during their athletic careers.</p><p>High levels of cardiorespiratory and muscular fitness are critical for athletes as they enhance athletic performance and reduce the risk of muscular injury. In high-performance sports, even small differences in <inline-formula><mml:math id="mm520" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max can have a significant impact on fitness outcomes [<xref rid="B48-sports-13-00040" ref-type="bibr">48</xref>]. Chen et al. (20-22) demonstrated that a reduction of 2.5 mL/kg/min in <inline-formula><mml:math id="mm65005" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max during two weeks of detraining resulted in decreased muscle strength and induced hemodynamic and muscular adaptations [<xref rid="B67-sports-13-00040" ref-type="bibr">67</xref>]. A reduction of 6&#x02013;8 mL/kg/min in <inline-formula><mml:math id="mm25" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max represents a significant decrease in aerobic capacity, with potential implications for endurance, recovery, and overall athletic performance. Although data in the literature indicate a satisfactory return of <inline-formula><mml:math id="mm51" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max three months after infection in competitive athletes, especially in mixed teams and asymptomatic individuals [<xref rid="B27-sports-13-00040" ref-type="bibr">27</xref>], returning to training with exhaustive and excessive exercise after SARS-CoV-2 infection can compromise cardiorespiratory function [<xref rid="B68-sports-13-00040" ref-type="bibr">68</xref>,<xref rid="B69-sports-13-00040" ref-type="bibr">69</xref>]. This results in a dysregulated systemic inflammatory response and a significant reduction in immune system function [<xref rid="B70-sports-13-00040" ref-type="bibr">70</xref>]. As elite athletes often feel pressure to return to training and competition as quickly as possible, the resumption of intense exercise may promote the development of persistent COVID-19 symptoms, even in those who were asymptomatic or experienced mild disease symptoms [<xref rid="B68-sports-13-00040" ref-type="bibr">68</xref>].</p><p>The data highlight concerns about the risk of long-term silent symptoms, even in athletes who experienced mild to moderate symptoms during COVID-19. Therefore, we recommend that the multidisciplinary sports health care team and coaches implement individualized return-to-training protocols, including a gradual progression in the frequency and intensity of activities, while avoiding high-intensity exercise initially. It is essential to monitor cardiorespiratory testing, such as CPET, to track aerobic conditioning throughout this process, allowing athletes to safely increase the training intensity without causing sequelae that could jeopardize their professional future [<xref rid="B68-sports-13-00040" ref-type="bibr">68</xref>].</p><p>Despite the promising findings, this study had some limitations that need to be addressed. Due to the inclusion of case studies and some analytical studies that presented the median rather than mean <inline-formula><mml:math id="mm55525" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max value, it is unclear whether the significance found in the pooled analysis is representative of the athlete&#x02019;s population. The absence of data on age, sex, and BMI in some of the included studies could represent possible selection bias and may have contributed to the exaggeration of the effect estimated in the linear regression analysis. A few athletes who were more severely affected by the infection may have had a longer recovery period without physical activity, resulting in lower VO<sub>2</sub>max values. Because some of the studies in this systematic review evaluated athletes from mixed modalities (aerobic and anaerobic), it was not possible to perform a stratified analysis, as this could introduce systematic error into our interpretation. In addition, because we are using aggregated data, stratification could potentially underestimate statistical power, thereby compromising the quality of the study. Furthermore, various studies were performed with elite and non-elite athletes [<xref rid="B6-sports-13-00040" ref-type="bibr">6</xref>,<xref rid="B7-sports-13-00040" ref-type="bibr">7</xref>,<xref rid="B11-sports-13-00040" ref-type="bibr">11</xref>,<xref rid="B13-sports-13-00040" ref-type="bibr">13</xref>,<xref rid="B25-sports-13-00040" ref-type="bibr">25</xref>,<xref rid="B27-sports-13-00040" ref-type="bibr">27</xref>,<xref rid="B29-sports-13-00040" ref-type="bibr">29</xref>,<xref rid="B30-sports-13-00040" ref-type="bibr">30</xref>,<xref rid="B32-sports-13-00040" ref-type="bibr">32</xref>], who most likely have different training protocols and outcomes during physical activity. However, a strength of this review is the relevant quality of the included observational studies, which achieved more than 70% of the STROBE checklist score. In addition, the pooled data from the included studies enable the analysis of a total of 2625 athletes who underwent CPET evaluation. Clinical variability in the persistent symptoms and the method used in CPET could have influenced the <inline-formula><mml:math id="mm525" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max levels and caused information bias in the analyzed data [<xref rid="B50-sports-13-00040" ref-type="bibr">50</xref>]. However, there was no difference between the treadmill and cycle ergometer methods in the studies included in this systematic review and meta-analysis.</p></sec><sec sec-type="conclusions" id="sec5-sports-13-00040"><title>5. Conclusions</title><p>This systematic review and meta-analysis found evidence that aerobic fitness is diminished after COVID-19. Although observational studies have reported that athletes recover their <inline-formula><mml:math id="mm5693" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max quickly after infection, those who underwent CPET at more than 12 weeks showed reduced exercise capacity, especially those with a higher BMI. Thus, this pooled analysis supports the implementation of a management guide for elite and non-elite athletes post-COVID-19, whether asymptomatic or symptomatic, to promote health and well-being, and avoid the sequelae of exercise intolerance and sports injuries upon return to training and competitions.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-sports-13-00040"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/sports13020040/s1">https://www.mdpi.com/article/10.3390/sports13020040/s1</uri>, Supplementary Table S1: <inline-formula><mml:math id="mm5111111111111111111" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max values with or without COVID-19 for the comparison groups [<xref rid="B5-sports-13-00040" ref-type="bibr">5</xref>,<xref rid="B6-sports-13-00040" ref-type="bibr">6</xref>,<xref rid="B7-sports-13-00040" ref-type="bibr">7</xref>,<xref rid="B8-sports-13-00040" ref-type="bibr">8</xref>,<xref rid="B9-sports-13-00040" ref-type="bibr">9</xref>,<xref rid="B10-sports-13-00040" ref-type="bibr">10</xref>,<xref rid="B11-sports-13-00040" ref-type="bibr">11</xref>,<xref rid="B12-sports-13-00040" ref-type="bibr">12</xref>,<xref rid="B13-sports-13-00040" ref-type="bibr">13</xref>,<xref rid="B16-sports-13-00040" ref-type="bibr">16</xref>,<xref rid="B22-sports-13-00040" ref-type="bibr">22</xref>,<xref rid="B27-sports-13-00040" ref-type="bibr">27</xref>,<xref rid="B28-sports-13-00040" ref-type="bibr">28</xref>,<xref rid="B30-sports-13-00040" ref-type="bibr">30</xref>,<xref rid="B32-sports-13-00040" ref-type="bibr">32</xref>,<xref rid="B33-sports-13-00040" ref-type="bibr">33</xref>,<xref rid="B38-sports-13-00040" ref-type="bibr">38</xref>,<xref rid="B39-sports-13-00040" ref-type="bibr">39</xref>,<xref rid="B40-sports-13-00040" ref-type="bibr">40</xref>].</p><supplementary-material id="sports-13-00040-s001" position="float" content-type="local-data"><media xlink:href="sports-13-00040-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, L.R.L., J.A.P., V.T., F.D. and R.M.; methodology, L.R.L., V.T. and F.D.; software, L.R.L.; validation, L.R.L., J.A.P., V.T., F.D. and R.M.; formal analysis, L.R.L., J.A.P., R.A.G. and R.M.; investigation, L.R.L., J.A.P., M.V.G.A., R.A.G., V.T., F.D. and R.M.; resources, L.R.L., J.A.P. and R.M.; data curation, L.R.L., V.T. and F.D.; writing&#x02014;original draft preparation, L.R.L., V.T. and F.D.; writing&#x02014;review and editing, J.A.P., M.V.G.A., R.A.G., R.M. and J.A.M.G.; visualization, J.A.P., M.V.G.A., R.A.G. and R.M.; supervision, R.M.; project administration, L.R.L., J.A.P. and R.M. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><glossary><title>Abbreviations</title><p>The following abbreviations are used in this manuscript:
<array><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">ACE</td><td align="left" valign="middle" rowspan="1" colspan="1">Angiotensin-converting enzyme</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ACE2</td><td align="left" valign="middle" rowspan="1" colspan="1">Angiotensin-converting enzyme 2</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ACSM</td><td align="left" valign="middle" rowspan="1" colspan="1">American College of Sports Medicine</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">AT</td><td align="left" valign="middle" rowspan="1" colspan="1">Anaerobic threshold</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">ATP</td><td align="left" valign="middle" rowspan="1" colspan="1">Adenosine triphosphate</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">BMI</td><td align="left" valign="middle" rowspan="1" colspan="1">Body mass index</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CI</td><td align="left" valign="middle" rowspan="1" colspan="1">Confidence interval</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CPET</td><td align="left" valign="middle" rowspan="1" colspan="1">Cardiopulmonary exercise test</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">IQR</td><td align="left" valign="middle" rowspan="1" colspan="1">Interquartile range</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PCR</td><td align="left" valign="middle" rowspan="1" colspan="1">Polymerase chain reaction</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PRISMA</td><td align="left" valign="middle" rowspan="1" colspan="1">Preferred Reporting Items for Systematic Reviews and Meta-analysis</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">RAS</td><td align="left" valign="middle" rowspan="1" colspan="1">Renin&#x02013;angiotensin system</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">S</td><td align="left" valign="middle" rowspan="1" colspan="1">Spike protein</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SD</td><td align="left" valign="middle" rowspan="1" colspan="1">Standard deviation</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SNP</td><td align="left" valign="middle" rowspan="1" colspan="1">Single-nucleotide polymorphism</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">STROBE</td><td align="left" valign="middle" rowspan="1" colspan="1">Strengthening the Reporting of Observational Studies in Epidemiology</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1"><inline-formula><mml:math id="mm5285" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max</td><td align="left" valign="middle" rowspan="1" colspan="1">Maximal oxygen uptake</td></tr></tbody></array></p></glossary><ref-list><title>References</title><ref id="B1-sports-13-00040"><label>1.</label><element-citation publication-type="webpage"><person-group person-group-type="author">
<collab>World Health Organization (WHO)</collab>
</person-group><article-title>Coronavirus (COVID-19) Dashboard</article-title><comment>Available online: <ext-link xlink:href="https://covid19.who.int/?mapFilter=cases" ext-link-type="uri">https://covid19.who.int/?mapFilter=cases</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-09-20">(accessed on 20 September 2024)</date-in-citation></element-citation></ref><ref id="B2-sports-13-00040"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ostolin</surname><given-names>T.L.V.D.P.</given-names></name>
<name><surname>Miranda</surname><given-names>R.A.D.R.</given-names></name>
<name><surname>Abdala</surname><given-names>C.V.M.</given-names></name>
</person-group><article-title>Evidence map on post-acute COVID-19 sequelae and rehabilitation: Update as of July 2022</article-title><source>Rev. Panam. Salud Publica</source><year>2023</year><volume>47</volume><fpage>e30</fpage><pub-id pub-id-type="pmid">36788961</pub-id>
</element-citation></ref><ref id="B3-sports-13-00040"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nalbandian</surname><given-names>A.</given-names></name>
<name><surname>Sehgal</surname><given-names>K.</given-names></name>
<name><surname>Gupta</surname><given-names>A.</given-names></name>
<name><surname>Madhavan</surname><given-names>M.V.</given-names></name>
<name><surname>McGroder</surname><given-names>C.</given-names></name>
<name><surname>Stevens</surname><given-names>J.S.</given-names></name>
<name><surname>Cook</surname><given-names>J.R.</given-names></name>
<name><surname>Nordvig</surname><given-names>A.N.</given-names></name>
<name><surname>Shalev</surname><given-names>D.</given-names></name>
<name><surname>Sehrawat</surname><given-names>T.S.</given-names></name>
<etal/>
</person-group><article-title>Post-acute COVID-19 syndrome</article-title><source>Nat. Med.</source><year>2021</year><volume>27</volume><fpage>601</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1038/s41591-021-01283-z</pub-id><pub-id pub-id-type="pmid">33753937</pub-id>
</element-citation></ref><ref id="B4-sports-13-00040"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Venkatesan</surname><given-names>P.</given-names></name>
</person-group><article-title>NICE guideline on long COVID</article-title><source>Lancet Respir. Med.</source><year>2021</year><volume>9</volume><fpage>129</fpage><pub-id pub-id-type="doi">10.1016/S2213-2600(21)00031-X</pub-id><pub-id pub-id-type="pmid">33453162</pub-id>
</element-citation></ref><ref id="B5-sports-13-00040"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barker-Davies</surname><given-names>R.M.</given-names></name>
<name><surname>Ladlow</surname><given-names>P.</given-names></name>
<name><surname>Chamley</surname><given-names>R.</given-names></name>
<name><surname>Nicol</surname><given-names>E.</given-names></name>
<name><surname>Holdsworth</surname><given-names>D.A.</given-names></name>
</person-group><article-title>Reduced athletic performance post-COVID-19 is associated with reduced anaerobic threshold</article-title><source>BMJ Case Rep.</source><year>2023</year><volume>16</volume><fpage>e250191</fpage><pub-id pub-id-type="doi">10.1136/bcr-2022-250191</pub-id><pub-id pub-id-type="pmid">36805865</pub-id>
</element-citation></ref><ref id="B6-sports-13-00040"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Komici</surname><given-names>K.</given-names></name>
<name><surname>Bianco</surname><given-names>A.</given-names></name>
<name><surname>Perrotta</surname><given-names>F.</given-names></name>
<name><surname>Dello Iacono</surname><given-names>A.</given-names></name>
<name><surname>Bencivenga</surname><given-names>L.</given-names></name>
<name><surname>D&#x02019;Agnano</surname><given-names>V.</given-names></name>
<name><surname>Rocca</surname><given-names>A.</given-names></name>
<name><surname>Bianco</surname><given-names>A.</given-names></name>
<name><surname>Rengo</surname><given-names>G.</given-names></name>
<name><surname>Guerra</surname><given-names>G.</given-names></name>
</person-group><article-title>Clinical Characteristics, Exercise Capacity and Pulmonary Function in Post-COVID-19 Competitive Athletes</article-title><source>J. Clin. Med.</source><year>2021</year><volume>10</volume><elocation-id>3053</elocation-id><pub-id pub-id-type="doi">10.3390/jcm10143053</pub-id><pub-id pub-id-type="pmid">34300219</pub-id>
</element-citation></ref><ref id="B7-sports-13-00040"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moulson</surname><given-names>N.</given-names></name>
<name><surname>Gustus</surname><given-names>S.K.</given-names></name>
<name><surname>Scirica</surname><given-names>C.</given-names></name>
<name><surname>Petek</surname><given-names>B.J.</given-names></name>
<name><surname>Vanatta</surname><given-names>C.</given-names></name>
<name><surname>Churchill</surname><given-names>T.W.</given-names></name>
<name><surname>Guseh</surname><given-names>J.S.</given-names></name>
<name><surname>Baggish</surname><given-names>A.</given-names></name>
<name><surname>Wasfy</surname><given-names>M.M.</given-names></name>
</person-group><article-title>Diagnostic evaluation and cardiopulmonary exercise test findings in young athletes with persistent symptoms following COVID-19</article-title><source>Br. J. Sports Med.</source><year>2022</year><volume>18</volume><fpage>105157</fpage><pub-id pub-id-type="doi">10.1136/bjsports-2021-105157</pub-id><pub-id pub-id-type="pmid">35584886</pub-id>
</element-citation></ref><ref id="B8-sports-13-00040"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nedeljkovic</surname><given-names>I.P.</given-names></name>
<name><surname>Giga</surname><given-names>V.</given-names></name>
<name><surname>Ostojic</surname><given-names>M.</given-names></name>
<name><surname>Djordjevic-Dikic</surname><given-names>A.</given-names></name>
<name><surname>Stojmenovic</surname><given-names>T.</given-names></name>
<name><surname>Nikolic</surname><given-names>I.</given-names></name>
<name><surname>Dikic</surname><given-names>N.</given-names></name>
<name><surname>Nedeljkovic-Arsenovic</surname><given-names>O.</given-names></name>
<name><surname>Maksimovic</surname><given-names>R.</given-names></name>
<name><surname>Dobric</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Focal Myocarditis after Mild COVID-19 Infection in Athletes</article-title><source>Diagnostics</source><year>2021</year><volume>11</volume><elocation-id>1519</elocation-id><pub-id pub-id-type="doi">10.3390/diagnostics11081519</pub-id><pub-id pub-id-type="pmid">34441453</pub-id>
</element-citation></ref><ref id="B9-sports-13-00040"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Parpa</surname><given-names>K.</given-names></name>
<name><surname>Michaelides</surname><given-names>M.</given-names></name>
</person-group><article-title>Aerobic capacity of professional soccer players before and after COVID-19 infection</article-title><source>Sci. Rep.</source><year>2022</year><volume>12</volume><elocation-id>11850</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-022-16031-7</pub-id><pub-id pub-id-type="pmid">35831351</pub-id>
</element-citation></ref><ref id="B10-sports-13-00040"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rao</surname><given-names>P.</given-names></name>
<name><surname>Peritz</surname><given-names>D.C.</given-names></name>
<name><surname>Systrom</surname><given-names>D.</given-names></name>
<name><surname>Lewine</surname><given-names>K.</given-names></name>
<name><surname>Cornwell</surname><given-names>W.K.</given-names></name>
<name><surname>Hsu</surname><given-names>J.J.</given-names></name>
</person-group><article-title>Orthostatic and Exercise Intolerance in Recreational and Competitive Athletes With Long COVID</article-title><source>JACC Case Rep.</source><year>2022</year><volume>4</volume><fpage>1119</fpage><lpage>1123</lpage><pub-id pub-id-type="doi">10.1016/j.jaccas.2022.07.007</pub-id><pub-id pub-id-type="pmid">36090156</pub-id>
</element-citation></ref><ref id="B11-sports-13-00040"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rudofker</surname><given-names>E.W.</given-names></name>
<name><surname>Parker</surname><given-names>H.</given-names></name>
<name><surname>Cornwell</surname><given-names>W.K.</given-names><suffix>3rd</suffix></name>
</person-group><article-title>An Exercise Prescription as a Novel Management Strategy for Treatment of Long COVID</article-title><source>JACC Case Rep.</source><year>2022</year><volume>4</volume><fpage>1344</fpage><lpage>1347</lpage><pub-id pub-id-type="doi">10.1016/j.jaccas.2022.06.026</pub-id><pub-id pub-id-type="pmid">36278147</pub-id>
</element-citation></ref><ref id="B12-sports-13-00040"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vollrath</surname><given-names>S.</given-names></name>
<name><surname>Bizjak</surname><given-names>D.A.</given-names></name>
<name><surname>Zorn</surname><given-names>J.</given-names></name>
<name><surname>Matits</surname><given-names>L.</given-names></name>
<name><surname>Jerg</surname><given-names>A.</given-names></name>
<name><surname>Munk</surname><given-names>M.</given-names></name>
<name><surname>Schulz</surname><given-names>S.V.W.</given-names></name>
<name><surname>Kirsten</surname><given-names>J.</given-names></name>
<name><surname>Schellenberg</surname><given-names>J.</given-names></name>
<name><surname>Steinacker</surname><given-names>J.M.</given-names></name>
<etal/>
</person-group><article-title>Recovery of performance and persistent symptoms in athletes after COVID-19</article-title><source>PLoS ONE</source><year>2022</year><volume>17</volume><elocation-id>e0277984</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0277984</pub-id><pub-id pub-id-type="pmid">36477204</pub-id>
</element-citation></ref><ref id="B13-sports-13-00040"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wernhart</surname><given-names>S.</given-names></name>
<name><surname>Weihe</surname><given-names>E.</given-names></name>
<name><surname>Totzeck</surname><given-names>M.</given-names></name>
<name><surname>Balcer</surname><given-names>B.</given-names></name>
<name><surname>Rassaf</surname><given-names>T.</given-names></name>
<name><surname>Luedike</surname><given-names>P.</given-names></name>
</person-group><article-title>Cardiopulmonary Profiling of Athletes with Post-Exertional Malaise after COVID-19 Infection-A Single-Center Experience</article-title><source>J. Clin. Med.</source><year>2023</year><volume>12</volume><elocation-id>4348</elocation-id><pub-id pub-id-type="doi">10.3390/jcm12134348</pub-id><pub-id pub-id-type="pmid">37445382</pub-id>
</element-citation></ref><ref id="B14-sports-13-00040"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alkodaymi</surname><given-names>M.S.</given-names></name>
<name><surname>Omrani</surname><given-names>O.A.</given-names></name>
<name><surname>Fawzy</surname><given-names>N.A.</given-names></name>
<name><surname>Shaar</surname><given-names>B.A.</given-names></name>
<name><surname>Almamlouk</surname><given-names>R.</given-names></name>
<name><surname>Riaz</surname><given-names>M.</given-names></name>
<name><surname>Obeidat</surname><given-names>M.</given-names></name>
<name><surname>Obeidat</surname><given-names>Y.</given-names></name>
<name><surname>Gerberi</surname><given-names>D.</given-names></name>
<name><surname>Taha</surname><given-names>R.M.</given-names></name>
<etal/>
</person-group><article-title>Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: A systematic review and meta-analysis</article-title><source>Clin. Microbiol. Infect.</source><year>2022</year><volume>28</volume><fpage>657</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1016/j.cmi.2022.01.014</pub-id><pub-id pub-id-type="pmid">35124265</pub-id>
</element-citation></ref><ref id="B15-sports-13-00040"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Petek</surname><given-names>B.J.</given-names></name>
<name><surname>Moulson</surname><given-names>N.</given-names></name>
<name><surname>Baggish</surname><given-names>A.L.</given-names></name>
<name><surname>Kliethermes</surname><given-names>S.A.</given-names></name>
<name><surname>Patel</surname><given-names>M.R.</given-names></name>
<name><surname>Churchill</surname><given-names>T.W.</given-names></name>
<name><surname>Harmon</surname><given-names>K.G.</given-names></name>
<name><surname>Drezner</surname><given-names>J.A.</given-names></name>
<collab>ORCCA Investigators</collab>
</person-group><article-title>Prevalence and clinical implications of persistent or exertional cardiopulmonary symptoms following SARS-CoV-2 infection in 3597 collegiate athletes: A study from the Outcomes Registry for Cardiac Conditions in Athletes (ORCCA)</article-title><source>Br. J. Sports Med.</source><year>2022</year><volume>56</volume><fpage>913</fpage><lpage>918</lpage><pub-id pub-id-type="doi">10.1136/bjsports-2021-104644</pub-id><pub-id pub-id-type="pmid">34725052</pub-id>
</element-citation></ref><ref id="B16-sports-13-00040"><label>16.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Brown</surname><given-names>K.D.</given-names></name>
<name><surname>Gilliland</surname><given-names>T.J.</given-names></name>
<name><surname>Reynolds</surname><given-names>M.</given-names></name>
<name><surname>McShan</surname><given-names>E.E.</given-names></name>
<name><surname>Driver</surname><given-names>S.</given-names></name>
</person-group><article-title>Reduction in cardiopulmonary and cognitive performance after COVID-19 in a competitive athlete</article-title><source>Baylor University Medical Center Proceedings</source><publisher-name>Taylor &#x00026; Francis</publisher-name><publisher-loc>Abingdon, UK</publisher-loc><year>2022</year><volume>Volume 36</volume><fpage>75</fpage><lpage>77</lpage></element-citation></ref><ref id="B17-sports-13-00040"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wilson</surname><given-names>M.G.</given-names></name>
<name><surname>Hull</surname><given-names>J.H.</given-names></name>
<name><surname>Rogers</surname><given-names>J.</given-names></name>
<name><surname>Pollock</surname><given-names>N.</given-names></name>
<name><surname>Dodd</surname><given-names>M.</given-names></name>
<name><surname>Haines</surname><given-names>J.</given-names></name>
<name><surname>Harris</surname><given-names>S.</given-names></name>
<name><surname>Loosemore</surname><given-names>M.</given-names></name>
<name><surname>Malhotra</surname><given-names>A.</given-names></name>
<name><surname>Pieles</surname><given-names>G.</given-names></name>
<etal/>
</person-group><article-title>Cardiorespiratory considerations for return-to-play in elite athletes after COVID-19 infection: A practical guide for sport and exercise medicine physicians</article-title><source>Br. J. Sports Med.</source><year>2020</year><volume>54</volume><fpage>1157</fpage><lpage>1161</lpage><pub-id pub-id-type="doi">10.1136/bjsports-2020-102710</pub-id><pub-id pub-id-type="pmid">32878870</pub-id>
</element-citation></ref><ref id="B18-sports-13-00040"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guazzi</surname><given-names>M.</given-names></name>
<name><surname>Adams</surname><given-names>V.</given-names></name>
<name><surname>Conraads</surname><given-names>V.</given-names></name>
<name><surname>Halle</surname><given-names>M.</given-names></name>
<name><surname>Mezzanim</surname><given-names>A.</given-names></name>
<name><surname>Vanheesm</surname><given-names>L.</given-names></name>
<name><surname>Arena</surname><given-names>R.</given-names></name>
<name><surname>Fletcher</surname><given-names>G.F.</given-names></name>
<name><surname>Forman</surname><given-names>D.E.</given-names></name>
<name><surname>Kitzman</surname><given-names>D.W.</given-names></name>
<etal/>
</person-group><article-title>EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations</article-title><source>Circulation</source><year>2012</year><volume>126</volume><fpage>2261</fpage><lpage>2274</lpage><pub-id pub-id-type="doi">10.1161/CIR.0b013e31826fb946</pub-id><pub-id pub-id-type="pmid">22952317</pub-id>
</element-citation></ref><ref id="B19-sports-13-00040"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tran</surname><given-names>D.</given-names></name>
</person-group><article-title>Cardiopulmonary Exercise Testing</article-title><source>Methods Mol. Biol.</source><year>2018</year><volume>1735</volume><fpage>285</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">29380321</pub-id>
</element-citation></ref><ref id="B20-sports-13-00040"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bye</surname><given-names>A.</given-names></name>
<name><surname>Klevjer</surname><given-names>M.</given-names></name>
<name><surname>Ryeng</surname><given-names>E.</given-names></name>
<name><surname>Silva</surname><given-names>G.J.J.D.</given-names></name>
<name><surname>Moreira</surname><given-names>J.B.N.</given-names></name>
<name><surname>Stensvold</surname><given-names>D.</given-names></name>
<name><surname>Wisl&#x000f8;ff</surname><given-names>U.</given-names></name>
</person-group><article-title>Identification of novel genetic variants associated with cardiorespiratory fitness</article-title><source>Prog. Cardiovasc. Dis.</source><year>2020</year><volume>63</volume><fpage>341</fpage><lpage>349</lpage><pub-id pub-id-type="doi">10.1016/j.pcad.2020.02.001</pub-id><pub-id pub-id-type="pmid">32035127</pub-id>
</element-citation></ref><ref id="B21-sports-13-00040"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Daems</surname><given-names>J.J.N.</given-names></name>
<name><surname>van Hattum</surname><given-names>J.C.</given-names></name>
<name><surname>Pinto</surname><given-names>Y.M.</given-names></name>
<name><surname>J&#x000f8;rstad</surname><given-names>H.T.</given-names></name>
</person-group><article-title>Case report: The role of multimodal imaging to optimize the timing of return to sports in an elite athlete with persistent COVID-19 myocardial inflammation</article-title><source>Eur. Heart J. Case Rep.</source><year>2022</year><volume>6</volume><fpage>ytac336</fpage><pub-id pub-id-type="doi">10.1093/ehjcr/ytac336</pub-id><pub-id pub-id-type="pmid">36043214</pub-id>
</element-citation></ref><ref id="B22-sports-13-00040"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fikenzer</surname><given-names>S.</given-names></name>
<name><surname>Kogel</surname><given-names>A.</given-names></name>
<name><surname>Pietsch</surname><given-names>C.</given-names></name>
<name><surname>Lavall</surname><given-names>D.</given-names></name>
<name><surname>St&#x000f6;be</surname><given-names>S.</given-names></name>
<name><surname>Rudolph</surname><given-names>U.</given-names></name>
<name><surname>Laufs</surname><given-names>U.</given-names></name>
<name><surname>Hepp</surname><given-names>P.</given-names></name>
<name><surname>Hagendorff</surname><given-names>A.</given-names></name>
</person-group><article-title>SARS-CoV2 infection: Functional and morphological cardiopulmonary changes in elite handball players</article-title><source>Sci. Rep.</source><year>2021</year><volume>11</volume><elocation-id>17798</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-021-97120-x</pub-id><pub-id pub-id-type="pmid">34493765</pub-id>
</element-citation></ref><ref id="B23-sports-13-00040"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stojmenovic</surname><given-names>D.</given-names></name>
<name><surname>Stojmenovic</surname><given-names>T.</given-names></name>
<name><surname>Andjelkovic</surname><given-names>M.</given-names></name>
<name><surname>Trunic</surname><given-names>N.</given-names></name>
<name><surname>Dikic</surname><given-names>N.</given-names></name>
<name><surname>Kilibarda</surname><given-names>N.</given-names></name>
<name><surname>Nikolic</surname><given-names>I.</given-names></name>
<name><surname>Nedeljkovic</surname><given-names>I.</given-names></name>
<name><surname>Ostojic</surname><given-names>M.</given-names></name>
<name><surname>Purkovic</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>The Influence of Different SARS-CoV-2 Strains on Changes in Maximal Oxygen Consumption, Ventilatory Efficiency and Oxygen Pulse of Elite Athletes</article-title><source>Diagnostics</source><year>2023</year><volume>13</volume><elocation-id>1574</elocation-id><pub-id pub-id-type="doi">10.3390/diagnostics13091574</pub-id><pub-id pub-id-type="pmid">37174965</pub-id>
</element-citation></ref><ref id="B24-sports-13-00040"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lorenz</surname><given-names>D.S.</given-names></name>
<name><surname>Reiman</surname><given-names>M.P.</given-names></name>
<name><surname>Lehecka</surname><given-names>B.J.</given-names></name>
<name><surname>Naylor</surname><given-names>A.</given-names></name>
</person-group><article-title>What performance characteristics determine elite versus nonelite athletes in the same sport?</article-title><source>Sports Health</source><year>2013</year><volume>5</volume><fpage>542</fpage><lpage>547</lpage><pub-id pub-id-type="doi">10.1177/1941738113479763</pub-id><pub-id pub-id-type="pmid">24427430</pub-id>
</element-citation></ref><ref id="B25-sports-13-00040"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>&#x0015a;li&#x0017c;</surname><given-names>D.</given-names></name>
<name><surname>Wiecha</surname><given-names>S.</given-names></name>
<name><surname>G&#x00105;sior</surname><given-names>J.S.</given-names></name>
<name><surname>Kasiak</surname><given-names>P.S.</given-names></name>
<name><surname>Ulaszewska</surname><given-names>K.</given-names></name>
<name><surname>Postu&#x00142;a</surname><given-names>M.</given-names></name>
<name><surname>Ma&#x00142;ek</surname><given-names>L.A.</given-names></name>
<name><surname>Mamcarz</surname><given-names>A.</given-names></name>
</person-group><article-title>The Influence of Nutrition and Physical Activity on Exercise Performance after Mild COVID-19 Infection in Endurance Athletes-CESAR Study</article-title><source>Nutrients</source><year>2022</year><volume>14</volume><elocation-id>5381</elocation-id><pub-id pub-id-type="doi">10.3390/nu14245381</pub-id><pub-id pub-id-type="pmid">36558540</pub-id>
</element-citation></ref><ref id="B26-sports-13-00040"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cuschieri</surname><given-names>S.</given-names></name>
</person-group><article-title>The STROBE guidelines</article-title><source>Saudi J. Anaesth.</source><year>2019</year><volume>13</volume><fpage>S31</fpage><lpage>S34</lpage><pub-id pub-id-type="doi">10.4103/sja.SJA_543_18</pub-id><pub-id pub-id-type="pmid">30930717</pub-id>
</element-citation></ref><ref id="B27-sports-13-00040"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Babity</surname><given-names>M.</given-names></name>
<name><surname>Zamodics</surname><given-names>M.</given-names></name>
<name><surname>Konig</surname><given-names>A.</given-names></name>
<name><surname>Kiss</surname><given-names>A.R.</given-names></name>
<name><surname>Horvath</surname><given-names>M.</given-names></name>
<name><surname>Gregor</surname><given-names>Z.</given-names></name>
<name><surname>Rakoczi</surname><given-names>R.</given-names></name>
<name><surname>Kovacs</surname><given-names>E.</given-names></name>
<name><surname>Fabian</surname><given-names>A.</given-names></name>
<name><surname>Tokodi</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Cardiopulmonary examinations of athletes returning to high-intensity sport activity following SARS-CoV-2 infection</article-title><source>Sci. Rep.</source><year>2022</year><volume>12</volume><elocation-id>21686</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-022-24486-x</pub-id><pub-id pub-id-type="pmid">36522351</pub-id>
</element-citation></ref><ref id="B28-sports-13-00040"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Csulak</surname><given-names>E.</given-names></name>
<name><surname>Petrov</surname><given-names>&#x000c1;.</given-names></name>
<name><surname>Kov&#x000e1;ts</surname><given-names>T.</given-names></name>
<name><surname>Tokodi</surname><given-names>M.</given-names></name>
<name><surname>Lakatos</surname><given-names>B.</given-names></name>
<name><surname>Kov&#x000e1;cs</surname><given-names>A.</given-names></name>
<name><surname>Staub</surname><given-names>L.</given-names></name>
<name><surname>Suhai</surname><given-names>F.I.</given-names></name>
<name><surname>Szab&#x000f3;</surname><given-names>E.L.</given-names></name>
<name><surname>Dohy</surname><given-names>Z.</given-names></name>
<etal/>
</person-group><article-title>The Impact of COVID-19 on the Preparation for the Tokyo Olympics: A Comprehensive Performance Assessment of Top Swimmers</article-title><source>Int. J. Environ. Res. Public. Health</source><year>2021</year><volume>8</volume><elocation-id>9770</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph18189770</pub-id></element-citation></ref><ref id="B29-sports-13-00040"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>&#x0015a;li&#x0017c;</surname><given-names>D.</given-names></name>
<name><surname>Wiecha</surname><given-names>S.</given-names></name>
<name><surname>Ulaszewska</surname><given-names>K.</given-names></name>
<name><surname>G&#x00105;sior</surname><given-names>J.S.</given-names></name>
<name><surname>Lewandowski</surname><given-names>M.</given-names></name>
<name><surname>Kasiak</surname><given-names>P.S.</given-names></name>
<name><surname>Mamcarz</surname><given-names>A.</given-names></name>
</person-group><article-title>COVID-19 and athletes: Endurance sport and activity resilience study-CAESAR study</article-title><source>Front. Physiol.</source><year>2022</year><volume>13</volume><elocation-id>1078763</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2022.1078763</pub-id><pub-id pub-id-type="pmid">36589442</pub-id>
</element-citation></ref><ref id="B30-sports-13-00040"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>&#x0015a;li&#x0017c;</surname><given-names>D.</given-names></name>
<name><surname>Wiecha</surname><given-names>S.</given-names></name>
<name><surname>G&#x00105;sior</surname><given-names>J.S.</given-names></name>
<name><surname>Kasiak</surname><given-names>P.S.</given-names></name>
<name><surname>Ulaszewska</surname><given-names>K.</given-names></name>
<name><surname>Lewandowski</surname><given-names>M.</given-names></name>
<name><surname>Barylski</surname><given-names>M.</given-names></name>
<name><surname>Mamcarz</surname><given-names>A.</given-names></name>
</person-group><article-title>Impact of COVID-19 Infection on Cardiorespiratory Fitness, Sleep, and Psychology of Endurance Athletes-CAESAR Study</article-title><source>J. Clin. Med.</source><year>2023</year><volume>12</volume><elocation-id>3002</elocation-id><pub-id pub-id-type="doi">10.3390/jcm12083002</pub-id><pub-id pub-id-type="pmid">37109342</pub-id>
</element-citation></ref><ref id="B31-sports-13-00040"><label>31.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Lippincott</surname><given-names>W.</given-names></name>
</person-group><article-title>Wilkins7. Fitness Categories for Maximal Aerobic Power for Men and Women by Age updated from 2009 to 2013</article-title><source>ACSM&#x02019;s Health-Related Physical Fitness Assessment Manual</source><edition>5th ed.</edition><publisher-name>Lippincott Williams &#x00026; Wilkins</publisher-name><publisher-loc>Philadelphia, PA, USA</publisher-loc><year>2019</year></element-citation></ref><ref id="B32-sports-13-00040"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cavigli</surname><given-names>L.</given-names></name>
<name><surname>Frascaro</surname><given-names>F.</given-names></name>
<name><surname>Turchini</surname><given-names>F.</given-names></name>
<name><surname>Mochi</surname><given-names>N.</given-names></name>
<name><surname>Sarto</surname><given-names>P.</given-names></name>
<name><surname>Bianchi</surname><given-names>S.</given-names></name>
<name><surname>Parri</surname><given-names>A.</given-names></name>
<name><surname>Carraro</surname><given-names>N.</given-names></name>
<name><surname>Valente</surname><given-names>S.</given-names></name>
<name><surname>Focardi</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>A prospective study on the consequences of SARS-CoV-2 infection on the heart of young adult competitive athletes: Implications for a safe return-to-play</article-title><source>Int. J. Cardiol.</source><year>2021</year><volume>336</volume><fpage>130</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2021.05.042</pub-id><pub-id pub-id-type="pmid">34082008</pub-id>
</element-citation></ref><ref id="B33-sports-13-00040"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Keller</surname><given-names>K.</given-names></name>
<name><surname>Friedrich</surname><given-names>O.</given-names></name>
<name><surname>Treiber</surname><given-names>J.</given-names></name>
<name><surname>Quermann</surname><given-names>A.</given-names></name>
<name><surname>Friedmann-Bette</surname><given-names>B.</given-names></name>
</person-group><article-title>Former SARS-CoV-2 Infection Was Related to Decreased VO<sub>2</sub> Peak and Exercise Hypertension in Athletes</article-title><source>Diagnostics</source><year>2023</year><volume>13</volume><elocation-id>1792</elocation-id><pub-id pub-id-type="doi">10.3390/diagnostics13101792</pub-id><pub-id pub-id-type="pmid">37238276</pub-id>
</element-citation></ref><ref id="B34-sports-13-00040"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maestrini</surname><given-names>V.</given-names></name>
<name><surname>Penza</surname><given-names>M.</given-names></name>
<name><surname>Filomena</surname><given-names>D.</given-names></name>
<name><surname>Birtolo</surname><given-names>L.I.</given-names></name>
<name><surname>Monosilio</surname><given-names>S.</given-names></name>
<name><surname>Lemme</surname><given-names>E.</given-names></name>
<name><surname>Squeo</surname><given-names>M.R.</given-names></name>
<name><surname>Mango</surname><given-names>R.</given-names></name>
<name><surname>Di Gioia</surname><given-names>G.</given-names></name>
<name><surname>Serdoz</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Low prevalence of cardiac abnormalities in competitive athletes at return-to-play after COVID-19</article-title><source>J. Sci. Med. Sport.</source><year>2023</year><volume>26</volume><fpage>8</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1016/j.jsams.2022.10.015</pub-id><pub-id pub-id-type="pmid">36372623</pub-id>
</element-citation></ref><ref id="B35-sports-13-00040"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maestrini</surname><given-names>V.</given-names></name>
<name><surname>Filomena</surname><given-names>D.</given-names></name>
<name><surname>Birtolo</surname><given-names>L.I.</given-names></name>
<name><surname>Serdoz</surname><given-names>A.</given-names></name>
<name><surname>Fiore</surname><given-names>R.</given-names></name>
<name><surname>Tatangelo</surname><given-names>M.</given-names></name>
<name><surname>Lemme</surname><given-names>E.</given-names></name>
<name><surname>Squeo</surname><given-names>M.R.</given-names></name>
<name><surname>Mango</surname><given-names>R.</given-names></name>
<name><surname>Di Gioia</surname><given-names>G.</given-names></name>
<etal/>
</person-group><article-title>Systematic Cardiovascular Screening in Olympic Athletes before and after SARS-CoV-2 Infection</article-title><source>J. Clin. Med.</source><year>2022</year><volume>11</volume><elocation-id>3499</elocation-id><pub-id pub-id-type="doi">10.3390/jcm11123499</pub-id><pub-id pub-id-type="pmid">35743567</pub-id>
</element-citation></ref><ref id="B36-sports-13-00040"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Milovancev</surname><given-names>A.</given-names></name>
<name><surname>Avakumovic</surname><given-names>J.</given-names></name>
<name><surname>Lakicevic</surname><given-names>N.</given-names></name>
<name><surname>Stajer</surname><given-names>V.</given-names></name>
<name><surname>Korovljev</surname><given-names>D.</given-names></name>
<name><surname>Todorovic</surname><given-names>N.</given-names></name>
<name><surname>Bianco</surname><given-names>A.</given-names></name>
<name><surname>Maksimovic</surname><given-names>N.</given-names></name>
<name><surname>Ostojic</surname><given-names>S.</given-names></name>
<name><surname>Drid</surname><given-names>P.</given-names></name>
</person-group><article-title>Cardiorespiratory Fitness in Volleyball Athletes Following a COVID-19 Infection: A Cross-Sectional Study</article-title><source>Int. J. Environ. Res. Public. Health</source><year>2021</year><volume>18</volume><elocation-id>4059</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph18084059</pub-id><pub-id pub-id-type="pmid">33921458</pub-id>
</element-citation></ref><ref id="B37-sports-13-00040"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mitrani</surname><given-names>R.D.</given-names></name>
<name><surname>Alfadhli</surname><given-names>J.</given-names></name>
<name><surname>Lowery</surname><given-names>M.H.</given-names></name>
<name><surname>Best</surname><given-names>T.M.</given-names></name>
<name><surname>Hare</surname><given-names>J.M.</given-names></name>
<name><surname>Fishman</surname><given-names>J.</given-names></name>
<name><surname>Dong</surname><given-names>C.</given-names></name>
<name><surname>Siegel</surname><given-names>Y.</given-names></name>
<name><surname>Scavo</surname><given-names>V.</given-names></name>
<name><surname>Basham</surname><given-names>G.J.</given-names></name>
<etal/>
</person-group><article-title>Utility of exercise testing to assess athletes for post COVID-19 myocarditis</article-title><source>Am. Heart J. Plus</source><year>2022</year><volume>14</volume><fpage>100125</fpage><pub-id pub-id-type="doi">10.1016/j.ahjo.2022.100125</pub-id><pub-id pub-id-type="pmid">35378797</pub-id>
</element-citation></ref><ref id="B38-sports-13-00040"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Stavrou</surname><given-names>V.T.</given-names></name>
<name><surname>Kyriaki</surname><given-names>A.</given-names></name>
<name><surname>Vavougios</surname><given-names>G.D.</given-names></name>
<name><surname>Fatouros</surname><given-names>I.G.</given-names></name>
<name><surname>Metsios</surname><given-names>G.S.</given-names></name>
<name><surname>Kalabakas</surname><given-names>K.</given-names></name>
<name><surname>Karagiannis</surname><given-names>D.</given-names></name>
<name><surname>Daniil</surname><given-names>Z.</given-names></name>
<name><surname>Gourgoulianis</surname><given-names>K.I.</given-names></name>
<name><surname>&#x00392;asdekis</surname><given-names>G.</given-names></name>
</person-group><article-title>Athletes with mild post-COVID-19 symptoms experience increased respiratory and metabolic demands: A cross-sectional study</article-title><source>Sports Med. Health Sci.</source><year>2023</year><volume>5</volume><fpage>106</fpage><lpage>111</lpage><pub-id pub-id-type="doi">10.1016/j.smhs.2022.10.004</pub-id><pub-id pub-id-type="pmid">36312217</pub-id>
</element-citation></ref><ref id="B39-sports-13-00040"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brito</surname><given-names>G.M.</given-names></name>
<name><surname>do Prado</surname><given-names>D.M.L.</given-names></name>
<name><surname>Rezende</surname><given-names>D.A.</given-names></name>
<name><surname>de Matos</surname><given-names>L.D.N.J.</given-names></name>
<name><surname>Loturco</surname><given-names>I.</given-names></name>
<name><surname>Vieira</surname><given-names>M.L.C.</given-names></name>
<name><surname>Pinto</surname><given-names>A.L.S.P.</given-names></name>
<name><surname>Al&#x000f4;</surname><given-names>R.O.B.</given-names></name>
<name><surname>Albuquerque</surname><given-names>L.C.A.</given-names></name>
<name><surname>Bianchini</surname><given-names>F.R.</given-names></name>
<etal/>
</person-group><article-title>The utility of cardiopulmonary exercise testing in athletes and physically active individuals with or without persistent symptoms after COVID-19</article-title><source>Front. Med.</source><year>2023</year><volume>10</volume><elocation-id>1128414</elocation-id><pub-id pub-id-type="doi">10.3389/fmed.2023.1128414</pub-id></element-citation></ref><ref id="B40-sports-13-00040"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Anastasio</surname><given-names>F.</given-names></name>
<name><surname>LA Macchia</surname><given-names>T.</given-names></name>
<name><surname>Rossi</surname><given-names>G.</given-names></name>
<name><surname>D&#x02019;Abbondanza</surname><given-names>M.</given-names></name>
<name><surname>Curcio</surname><given-names>R.</given-names></name>
<name><surname>Vaudo</surname><given-names>G.</given-names></name>
<name><surname>Pucci</surname><given-names>G.</given-names></name>
</person-group><article-title>Mid-term impact of mild-moderate COVID-19 on cardiorespiratory fitness in &#x000e9;lite athletes</article-title><source>J. Sports Med. Phys. Fit.</source><year>2022</year><volume>62</volume><fpage>1383</fpage><lpage>1390</lpage><pub-id pub-id-type="doi">10.23736/S0022-4707.21.13226-8</pub-id><pub-id pub-id-type="pmid">34758007</pub-id>
</element-citation></ref><ref id="B41-sports-13-00040"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nieman</surname><given-names>D.C.</given-names></name>
<name><surname>Henson</surname><given-names>D.A.</given-names></name>
<name><surname>Austin</surname><given-names>M.D.</given-names></name>
<name><surname>Sha</surname><given-names>W.</given-names></name>
</person-group><article-title>Upper respiratory tract infection is reduced in physically fit and active adults</article-title><source>Br. J. Sports Med.</source><year>2011</year><volume>45</volume><fpage>987</fpage><lpage>992</lpage><pub-id pub-id-type="doi">10.1136/bjsm.2010.077875</pub-id><pub-id pub-id-type="pmid">21041243</pub-id>
</element-citation></ref><ref id="B42-sports-13-00040"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>Z.</given-names></name>
<name><surname>Shi</surname><given-names>L.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Zhang</surname><given-names>J.</given-names></name>
<name><surname>Huang</surname><given-names>L.</given-names></name>
<name><surname>Zhang</surname><given-names>C.</given-names></name>
<name><surname>Liu</surname><given-names>S.</given-names></name>
<name><surname>Zhao</surname><given-names>P.</given-names></name>
<name><surname>Liu</surname><given-names>H.</given-names></name>
<name><surname>Zhu</surname><given-names>L.</given-names></name>
<etal/>
</person-group><article-title>Pathological findings of COVID-19 associated with acute respiratory distress syndrome</article-title><source>Lancet Respir. Med.</source><year>2020</year><volume>8</volume><fpage>420</fpage><lpage>422</lpage><pub-id pub-id-type="doi">10.1016/S2213-2600(20)30076-X</pub-id><pub-id pub-id-type="pmid">32085846</pub-id>
</element-citation></ref><ref id="B43-sports-13-00040"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lopes</surname><given-names>L.R.</given-names></name>
<name><surname>Miranda</surname><given-names>V.A.</given-names></name>
<name><surname>Goes</surname><given-names>R.A.</given-names></name>
<name><surname>Souza</surname><given-names>G.G.</given-names></name>
<name><surname>Souza</surname><given-names>G.R.</given-names></name>
<name><surname>Rocha</surname><given-names>J.C.</given-names></name>
<name><surname>Cossich</surname><given-names>V.R.</given-names></name>
<name><surname>Perini</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Repercussions of the COVID-19 pandemic on athletes: A cross-sectional study</article-title><source>Biol. Sport.</source><year>2021</year><volume>38</volume><fpage>703</fpage><lpage>711</lpage><pub-id pub-id-type="doi">10.5114/biolsport.2021.106147</pub-id><pub-id pub-id-type="pmid">34937981</pub-id>
</element-citation></ref><ref id="B44-sports-13-00040"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gonzales</surname><given-names>T.I.</given-names></name>
<name><surname>Jeon</surname><given-names>J.Y.</given-names></name>
<name><surname>Lindsay</surname><given-names>T.</given-names></name>
<name><surname>Westgate</surname><given-names>K.</given-names></name>
<name><surname>Perez-Pozuelo</surname><given-names>I.</given-names></name>
<name><surname>Hollidge</surname><given-names>S.</given-names></name>
<name><surname>Wijndaele</surname><given-names>K.</given-names></name>
<name><surname>Rennie</surname><given-names>K.</given-names></name>
<name><surname>Forouhi</surname><given-names>N.</given-names></name>
<name><surname>Griffin</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Resting heart rate is a population-level biomarker of cardiorespiratory fitness: The Fenland Study</article-title><source>PLoS ONE</source><year>2023</year><volume>18</volume><elocation-id>e0285272</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0285272</pub-id><pub-id pub-id-type="pmid">37167327</pub-id>
</element-citation></ref><ref id="B45-sports-13-00040"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nieman</surname><given-names>D.C.</given-names></name>
</person-group><article-title>Risk of upper respiratory tract infection in athletes: An epidemiologic and immunologic perspective</article-title><source>J. Athl. Train.</source><year>1997</year><volume>32</volume><fpage>344</fpage><lpage>349</lpage><pub-id pub-id-type="pmid">16558471</pub-id>
</element-citation></ref><ref id="B46-sports-13-00040"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nieman</surname><given-names>D.C.</given-names></name>
<name><surname>Nehlsen-Cannarella</surname><given-names>S.L.</given-names></name>
<name><surname>Markoff</surname><given-names>P.A.</given-names></name>
<name><surname>Balk-Lamberton</surname><given-names>A.J.</given-names></name>
<name><surname>Yang</surname><given-names>H.</given-names></name>
<name><surname>Chritton</surname><given-names>D.B.</given-names></name>
<name><surname>Lee</surname><given-names>J.W.</given-names></name>
<name><surname>Arabatzis</surname><given-names>K.</given-names></name>
</person-group><article-title>The effects of moderate exercise training on natural killer cells and acute upper respiratory tract infections</article-title><source>Int. J. Sports Med.</source><year>1990</year><volume>11</volume><fpage>467</fpage><lpage>473</lpage><pub-id pub-id-type="doi">10.1055/s-2007-1024839</pub-id><pub-id pub-id-type="pmid">2286486</pub-id>
</element-citation></ref><ref id="B47-sports-13-00040"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Clavario</surname><given-names>P.</given-names></name>
<name><surname>De Marzo</surname><given-names>V.</given-names></name>
<name><surname>Lotti</surname><given-names>R.</given-names></name>
<name><surname>Barbara</surname><given-names>C.</given-names></name>
<name><surname>Porcile</surname><given-names>A.</given-names></name>
<name><surname>Russo</surname><given-names>C.</given-names></name>
<name><surname>Beccaria</surname><given-names>F.</given-names></name>
<name><surname>Bonavia</surname><given-names>M.</given-names></name>
<name><surname>Bottaro</surname><given-names>L.C.</given-names></name>
<name><surname>Caltabellotta</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up</article-title><source>Int. J. Cardiol.</source><year>2021</year><volume>340</volume><fpage>113</fpage><lpage>118</lpage><pub-id pub-id-type="doi">10.1016/j.ijcard.2021.07.033</pub-id><pub-id pub-id-type="pmid">34311011</pub-id>
</element-citation></ref><ref id="B48-sports-13-00040"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hull</surname><given-names>J.H.</given-names></name>
<name><surname>Wootten</surname><given-names>M.</given-names></name>
<name><surname>Moghal</surname><given-names>M.</given-names></name>
<name><surname>Heron</surname><given-names>N.</given-names></name>
<name><surname>Martin</surname><given-names>R.</given-names></name>
<name><surname>Walsted</surname><given-names>E.S.</given-names></name>
<name><surname>Biswas</surname><given-names>A.</given-names></name>
<name><surname>Loosemore</surname><given-names>M.</given-names></name>
<name><surname>Elliott</surname><given-names>N.</given-names></name>
<name><surname>Ranson</surname><given-names>C.</given-names></name>
</person-group><article-title>Clinical patterns, recovery time and prolonged impact of COVID-19 illness in international athletes: The UK experience</article-title><source>Br. J. Sports Med.</source><year>2022</year><volume>56</volume><fpage>4</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1136/bjsports-2021-104392</pub-id><pub-id pub-id-type="pmid">34340972</pub-id>
</element-citation></ref><ref id="B49-sports-13-00040"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vonbank</surname><given-names>K.</given-names></name>
<name><surname>Lehmann</surname><given-names>A.</given-names></name>
<name><surname>Bernitzky</surname><given-names>D.</given-names></name>
<name><surname>Gysan</surname><given-names>M.R.</given-names></name>
<name><surname>Simon</surname><given-names>S.</given-names></name>
<name><surname>Schrott</surname><given-names>A.</given-names></name>
<name><surname>Burtscher</surname><given-names>M.</given-names></name>
<name><surname>Idzko</surname><given-names>M.</given-names></name>
<name><surname>Gompelmann</surname><given-names>D.</given-names></name>
</person-group><article-title>Predictors of Prolonged Cardiopulmonary Exercise Impairment After COVID-19 Infection: A Prospective Observational Study</article-title><source>Front. Med.</source><year>2021</year><volume>8</volume><elocation-id>773788</elocation-id><pub-id pub-id-type="doi">10.3389/fmed.2021.773788</pub-id></element-citation></ref><ref id="B50-sports-13-00040"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Martinez</surname><given-names>M.W.</given-names></name>
<name><surname>Tucker</surname><given-names>A.M.</given-names></name>
<name><surname>Bloom</surname><given-names>O.J.</given-names></name>
<name><surname>Green</surname><given-names>G.</given-names></name>
<name><surname>DiFiori</surname><given-names>J.P.</given-names></name>
<name><surname>Solomon</surname><given-names>G.</given-names></name>
<name><surname>Phelan</surname><given-names>D.</given-names></name>
<name><surname>Kim</surname><given-names>J.H.</given-names></name>
<name><surname>Meeuwisse</surname><given-names>W.</given-names></name>
<name><surname>Sills</surname><given-names>A.K.</given-names></name>
<etal/>
</person-group><article-title>Prevalence of Inflammatory Heart Disease Among Professional Athletes With Prior COVID-19 Infection Who Received Systematic Return-to-Play Cardiac Screening</article-title><source>JAMA Cardiol.</source><year>2021</year><volume>6</volume><fpage>745</fpage><lpage>752</lpage><pub-id pub-id-type="doi">10.1001/jamacardio.2021.0565</pub-id><pub-id pub-id-type="pmid">33662103</pub-id>
</element-citation></ref><ref id="B51-sports-13-00040"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Durstenfeld</surname><given-names>M.S.</given-names></name>
<name><surname>Sun</surname><given-names>K.</given-names></name>
<name><surname>Tahir</surname><given-names>P.</given-names></name>
<name><surname>Peluso</surname><given-names>M.J.</given-names></name>
<name><surname>Deeks</surname><given-names>S.G.</given-names></name>
<name><surname>Aras</surname><given-names>M.A.</given-names></name>
<name><surname>Grandis</surname><given-names>D.J.</given-names></name>
<name><surname>Long</surname><given-names>C.S.</given-names></name>
<name><surname>Beatty</surname><given-names>A.</given-names></name>
<name><surname>Hsue</surname><given-names>P.Y.</given-names></name>
</person-group><article-title>Use of Cardiopulmonary Exercise Testing to Evaluate Long COVID-19 Symptoms in Adults: A Systematic Review and Meta-analysis</article-title><source>JAMA Netw. Open</source><year>2022</year><volume>5</volume><fpage>e2236057</fpage><pub-id pub-id-type="doi">10.1001/jamanetworkopen.2022.36057</pub-id><pub-id pub-id-type="pmid">36223120</pub-id>
</element-citation></ref><ref id="B52-sports-13-00040"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Letnes</surname><given-names>J.M.</given-names></name>
<name><surname>Nes</surname><given-names>B.M.</given-names></name>
<name><surname>Wisl&#x000f8;ff</surname><given-names>U.</given-names></name>
</person-group><article-title>Age-related decline in peak oxygen uptake: Cross-sectional vs. longitudinal findings. A review</article-title><source>Int. J. Cardiol. Cardiovasc. Risk Prev.</source><year>2023</year><volume>16</volume><fpage>200171</fpage><pub-id pub-id-type="doi">10.1016/j.ijcrp.2023.200171</pub-id><pub-id pub-id-type="pmid">36874046</pub-id>
</element-citation></ref><ref id="B53-sports-13-00040"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>de Subijana</surname><given-names>C.L.</given-names></name>
<name><surname>Galatti</surname><given-names>L.</given-names></name>
<name><surname>Moreno</surname><given-names>R.</given-names></name>
<name><surname>Chamorro</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Analysis of the Athletic Career and Retirement Depending on the Type of Sport: A Comparison between Individual and Team Sports</article-title><source>Int. J. Environ. Res. Public. Health</source><year>2020</year><volume>17</volume><elocation-id>9265</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph17249265</pub-id><pub-id pub-id-type="pmid">33322365</pub-id>
</element-citation></ref><ref id="B54-sports-13-00040"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Atakan</surname><given-names>M.M.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Ko&#x0015f;ar</surname><given-names>&#x0015e;.N.</given-names></name>
<name><surname>Turnag&#x000f6;l</surname><given-names>H.H.</given-names></name>
<name><surname>Yan</surname><given-names>X.</given-names></name>
</person-group><article-title>Evidence-Based Effects of High-Intensity Interval Training on Exercise Capacity and Health: A Review with Historical Perspective</article-title><source>Int. J. Environ. Res. Public. Health</source><year>2021</year><volume>18</volume><elocation-id>7201</elocation-id><pub-id pub-id-type="doi">10.3390/ijerph18137201</pub-id><pub-id pub-id-type="pmid">34281138</pub-id>
</element-citation></ref><ref id="B55-sports-13-00040"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xavier</surname><given-names>R.</given-names></name>
<name><surname>S&#x000e1;nchez</surname><given-names>C.</given-names></name>
<name><surname>Paulucio</surname><given-names>D.</given-names></name>
<name><surname>da Silva</surname><given-names>I.M.</given-names></name>
<name><surname>Velasque</surname><given-names>R.</given-names></name>
<name><surname>Nogueira</surname><given-names>F.S.</given-names></name>
<name><surname>Ferrini</surname><given-names>L.S.G.</given-names></name>
<name><surname>Dornelas Ribeiro</surname><given-names>M.</given-names></name>
<name><surname>Serrato</surname><given-names>M.</given-names></name>
<name><surname>Alvarenga</surname><given-names>R.</given-names></name>
<etal/>
</person-group><article-title>A Multidimensional Approach to Assessing Anthropometric and Aerobic Fitness Profiles of Elite Brazilian Endurance Athletes and Military Personnel</article-title><source>Mil. Med.</source><year>2019</year><volume>184</volume><fpage>875</fpage><lpage>881</lpage><pub-id pub-id-type="doi">10.1093/milmed/usz003</pub-id><pub-id pub-id-type="pmid">30941410</pub-id>
</element-citation></ref><ref id="B56-sports-13-00040"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Spyrou</surname><given-names>K.</given-names></name>
<name><surname>Freitas</surname><given-names>T.T.</given-names></name>
<name><surname>Mar&#x000ed;n-Cascales</surname><given-names>E.</given-names></name>
<name><surname>Alcaraz</surname><given-names>P.E.</given-names></name>
</person-group><article-title>Physical and Physiological Match-Play Demands and Player Characteristics in Futsal: A Systematic Review</article-title><source>Front. Psychol.</source><year>2020</year><volume>11</volume><elocation-id>569897</elocation-id><pub-id pub-id-type="doi">10.3389/fpsyg.2020.569897</pub-id><pub-id pub-id-type="pmid">33240157</pub-id>
</element-citation></ref><ref id="B57-sports-13-00040"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>J.J.</given-names></name>
<name><surname>Dong</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>G.H.</given-names></name>
<name><surname>Gao</surname><given-names>Y.D.</given-names></name>
</person-group><article-title>Risk and Protective Factors for COVID-19 Morbidity, Severity, and Mortality</article-title><source>Clin. Rev. Allergy Immunol.</source><year>2023</year><volume>64</volume><fpage>90</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1007/s12016-022-08921-5</pub-id><pub-id pub-id-type="pmid">35044620</pub-id>
</element-citation></ref><ref id="B58-sports-13-00040"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Perez-Valera</surname><given-names>M.</given-names></name>
<name><surname>Martinez-Canton</surname><given-names>M.</given-names></name>
<name><surname>Gallego-Selles</surname><given-names>A.</given-names></name>
<name><surname>Galv&#x000e1;n-Alvarez</surname><given-names>V.</given-names></name>
<name><surname>Gelabert-Rebato</surname><given-names>M.</given-names></name>
<name><surname>Morales-Alamo</surname><given-names>D.</given-names></name>
<name><surname>Santana</surname><given-names>A.</given-names></name>
<name><surname>Martin-Rodriguez</surname><given-names>S.</given-names></name>
<name><surname>Ponce-Gonzalez</surname><given-names>J.G.</given-names></name>
<name><surname>Larsen</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Angiotensin-Converting Enzyme 2 (SARS-CoV-2 receptor) expression in human skeletal muscle</article-title><source>Scand. J. Med. Sci. Sports</source><year>2021</year><volume>31</volume><fpage>2249</fpage><lpage>2258</lpage><pub-id pub-id-type="doi">10.1111/sms.14061</pub-id><pub-id pub-id-type="pmid">34551157</pub-id>
</element-citation></ref><ref id="B59-sports-13-00040"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mascolo</surname><given-names>A.</given-names></name>
<name><surname>Scavone</surname><given-names>C.</given-names></name>
<name><surname>Rafaniello</surname><given-names>C.</given-names></name>
<name><surname>De Angelis</surname><given-names>A.</given-names></name>
<name><surname>Urbanek</surname><given-names>K.</given-names></name>
<name><surname>di Mauro</surname><given-names>G.</given-names></name>
<name><surname>Cappetta</surname><given-names>D.</given-names></name>
<name><surname>Berrino</surname><given-names>L.</given-names></name>
<name><surname>Rossi</surname><given-names>F.</given-names></name>
<name><surname>Capuano</surname><given-names>A.</given-names></name>
</person-group><article-title>The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19</article-title><source>Front. Pharmacol.</source><year>2021</year><volume>12</volume><elocation-id>667254</elocation-id><pub-id pub-id-type="doi">10.3389/fphar.2021.667254</pub-id><pub-id pub-id-type="pmid">33959029</pub-id>
</element-citation></ref><ref id="B60-sports-13-00040"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Arazi</surname><given-names>H.</given-names></name>
<name><surname>Falahati</surname><given-names>A.</given-names></name>
<name><surname>Suzuki</surname><given-names>K.</given-names></name>
</person-group><article-title>Moderate Intensity Aerobic Exercise Potential Favorable Effect Against COVID-19: The Role of Renin-Angiotensin System and Immunomodulatory Effects</article-title><source>Front. Physiol.</source><year>2021</year><volume>12</volume><elocation-id>747200</elocation-id><pub-id pub-id-type="doi">10.3389/fphys.2021.747200</pub-id><pub-id pub-id-type="pmid">34867452</pub-id>
</element-citation></ref><ref id="B61-sports-13-00040"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Daniel</surname><given-names>G.</given-names></name>
<name><surname>Paola</surname><given-names>A.R.</given-names></name>
<name><surname>Nancy</surname><given-names>G.</given-names></name>
<name><surname>Fernando</surname><given-names>S.O.</given-names></name>
<name><surname>Beatriz</surname><given-names>A.</given-names></name>
<name><surname>Zulema</surname><given-names>R.</given-names></name>
<name><surname>Julieth</surname><given-names>A.</given-names></name>
<name><surname>Claudia</surname><given-names>C.</given-names></name>
<name><surname>Adriana</surname><given-names>R.</given-names></name>
</person-group><article-title>Epigenetic mechanisms and host factors impact ACE2 gene expression: Implications in COVID-19 susceptibility</article-title><source>Infect. Genet. Evol.</source><year>2022</year><volume>104</volume><fpage>105357</fpage><pub-id pub-id-type="doi">10.1016/j.meegid.2022.105357</pub-id><pub-id pub-id-type="pmid">36038007</pub-id>
</element-citation></ref><ref id="B62-sports-13-00040"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Meyler</surname><given-names>S.</given-names></name>
<name><surname>Bottoms</surname><given-names>L.</given-names></name>
<name><surname>Muniz-Pumares</surname><given-names>D.</given-names></name>
</person-group><article-title>Biological and methodological factors affecting <inline-formula><mml:math id="mm87525" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max response variability to endurance training and the influence of exercise intensity prescription</article-title><source>Exp. Physiol.</source><year>2021</year><volume>106</volume><fpage>1410</fpage><lpage>1424</lpage><pub-id pub-id-type="doi">10.1113/EP089565</pub-id><pub-id pub-id-type="pmid">34036650</pub-id>
</element-citation></ref><ref id="B63-sports-13-00040"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhao</surname><given-names>B.</given-names></name>
<name><surname>Moochhala</surname><given-names>S.M.</given-names></name>
<name><surname>Tham</surname><given-names>S.Y.</given-names></name>
<name><surname>Lu</surname><given-names>J.</given-names></name>
<name><surname>Chia</surname><given-names>M.</given-names></name>
<name><surname>Byrne</surname><given-names>C.</given-names></name>
<name><surname>Hu</surname><given-names>Q.</given-names></name>
<name><surname>Lee</surname><given-names>L.K.</given-names></name>
</person-group><article-title>Relationship between angiotensin-converting enzyme ID polymorphism and VO&#x02082;max of Chinese males</article-title><source>Life Sci.</source><year>2003</year><volume>73</volume><fpage>2625</fpage><lpage>2630</lpage><pub-id pub-id-type="doi">10.1016/S0024-3205(03)00608-8</pub-id><pub-id pub-id-type="pmid">12967686</pub-id>
</element-citation></ref><ref id="B64-sports-13-00040"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>de Almeida</surname><given-names>K.Y.</given-names></name>
<name><surname>Cetolin</surname><given-names>T.</given-names></name>
<name><surname>Marrero</surname><given-names>A.R.</given-names></name>
<name><surname>Aguiar Junior</surname><given-names>A.S.</given-names></name>
<name><surname>Mohr</surname><given-names>P.</given-names></name>
<name><surname>Kikuchi</surname><given-names>N.</given-names></name>
</person-group><article-title>A Pilot Study on the Prediction of Non-Contact Muscle Injuries Based on ACTN3 R577X and ACE I/D Polymorphisms in Professional Soccer Athletes</article-title><source>Genes</source><year>2022</year><volume>13</volume><elocation-id>2009</elocation-id><pub-id pub-id-type="doi">10.3390/genes13112009</pub-id><pub-id pub-id-type="pmid">36360246</pub-id>
</element-citation></ref><ref id="B65-sports-13-00040"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fricke-Galindo</surname><given-names>I.</given-names></name>
<name><surname>Buendia-Roldan</surname><given-names>I.</given-names></name>
<name><surname>Ponce-Aguilar</surname><given-names>D.I.</given-names></name>
<name><surname>P&#x000e9;rez-Rubio</surname><given-names>G.</given-names></name>
<name><surname>Chavez-Galan</surname><given-names>L.</given-names></name>
<name><surname>Alanis-Ponce</surname><given-names>J.</given-names></name>
<name><surname>P&#x000e9;rez-Torres</surname><given-names>K.</given-names></name>
<name><surname>Valencia-P&#x000e9;rez Rea</surname><given-names>D.</given-names></name>
<name><surname>T&#x000e9;llez-Quijada</surname><given-names>F.</given-names></name>
<name><surname>Nava-Quiroz</surname><given-names>K.J.</given-names></name>
<etal/>
</person-group><article-title>The ACE rs1799752 Variant Is Associated with COVID-19 Severity but Is Independent of Serum ACE Activity in Hospitalized and Recovered Patients</article-title><source>Int. J. Mol. Sci.</source><year>2023</year><volume>24</volume><elocation-id>7678</elocation-id><pub-id pub-id-type="doi">10.3390/ijms24087678</pub-id><pub-id pub-id-type="pmid">37108839</pub-id>
</element-citation></ref><ref id="B66-sports-13-00040"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lopes</surname><given-names>L.R.</given-names></name>
<name><surname>de Souza</surname><given-names>G.R.</given-names></name>
<name><surname>Goes</surname><given-names>R.A.</given-names></name>
<name><surname>Amaral</surname><given-names>V.G.</given-names></name>
<name><surname>Guimar&#x000e3;es</surname><given-names>J.A.M.</given-names></name>
<name><surname>Cossich</surname><given-names>V.R.A.</given-names></name>
<name><surname>Perini</surname><given-names>J.A.</given-names></name>
</person-group><article-title>Association between depressive symptoms and episodes of musculoskeletal injuries in Brazilian athletes during crisis time</article-title><source>Am. J. Sports Sci. Med.</source><year>2023</year><volume>11</volume><fpage>22</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.12691/ajssm-11-1-3</pub-id></element-citation></ref><ref id="B67-sports-13-00040"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>Y.T.</given-names></name>
<name><surname>Hsieh</surname><given-names>Y.Y.</given-names></name>
<name><surname>Ho</surname><given-names>J.Y.</given-names></name>
<name><surname>Lin</surname><given-names>T.Y.</given-names></name>
<name><surname>Lin</surname><given-names>J.C.</given-names></name>
</person-group><article-title>Two weeks of detraining reduces cardiopulmonary function and muscular fitness in endurance athletes</article-title><source>Eur. J. Sport Sci.</source><year>2022</year><volume>22</volume><fpage>399</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1080/17461391.2021.1880647</pub-id><pub-id pub-id-type="pmid">33517866</pub-id>
</element-citation></ref><ref id="B68-sports-13-00040"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Villano</surname><given-names>M.</given-names></name>
<name><surname>Spaniol</surname><given-names>F.</given-names></name>
</person-group><article-title>The effects of COVID-19 infection on athletic performance: A systematic review</article-title><source>Sport. J.</source><year>2024</year><volume>24</volume><comment>Available online: <ext-link xlink:href="https://thesportjournal.org/article/title-the-effects-of-covid-19-infection-on-athletic-performance-a-systematic-review/" ext-link-type="uri">https://thesportjournal.org/article/title-the-effects-of-covid-19-infection-on-athletic-performance-a-systematic-review/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-01-15">(accessed on 15 January 2025)</date-in-citation></element-citation></ref><ref id="B69-sports-13-00040"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wezenbeek</surname><given-names>E.</given-names></name>
<name><surname>Denolf</surname><given-names>S.</given-names></name>
<name><surname>Bourgois</surname><given-names>J.G.</given-names></name>
<name><surname>Philippaerts</surname><given-names>R.M.</given-names></name>
<name><surname>De Winne</surname><given-names>B.</given-names></name>
<name><surname>Willems</surname><given-names>T.M.</given-names></name>
<name><surname>Witvrouw</surname><given-names>E.</given-names></name>
<name><surname>Verstockt</surname><given-names>S.</given-names></name>
<name><surname>Schuermans</surname><given-names>J.</given-names></name>
</person-group><article-title>Impact of (long) COVID on athletes&#x02019; performance: A prospective study in elite football players</article-title><source>Ann. Med.</source><year>2023</year><volume>55</volume><fpage>2198776</fpage><pub-id pub-id-type="doi">10.1080/07853890.2023.2198776</pub-id><pub-id pub-id-type="pmid">37126052</pub-id>
</element-citation></ref><ref id="B70-sports-13-00040"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nien</surname><given-names>J.T.</given-names></name>
<name><surname>Wu</surname><given-names>C.H.</given-names></name>
<name><surname>Yang</surname><given-names>K.T.</given-names></name>
<name><surname>Cho</surname><given-names>Y.M.</given-names></name>
<name><surname>Chu</surname><given-names>C.H.</given-names></name>
<name><surname>Chang</surname><given-names>Y.K.</given-names></name>
<name><surname>Zhou</surname><given-names>C.</given-names></name>
</person-group><article-title>Mindfulness Training Enhances Endurance Performance and Executive Functions in Athletes: An Event-Related Potential Study</article-title><source>Neural Plast.</source><year>2020</year><volume>2020</volume><fpage>8213710</fpage><pub-id pub-id-type="doi">10.1155/2020/8213710</pub-id><pub-id pub-id-type="pmid">32908483</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="sports-13-00040-f001"><label>Figure 1</label><caption><p>Flowchart of observational studies included in the systematic review and meta-analysis.</p></caption><graphic xlink:href="sports-13-00040-g001" position="float"/></fig><fig position="float" id="sports-13-00040-f002"><label>Figure 2</label><caption><p>(<bold>A</bold>) Frequency of male and female athletes analyzed in each study. (<bold>B</bold>) Comparison of mean <inline-formula><mml:math id="mm99525" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max among symptomatic and asymptomatic post-COVID-19 athletes and those without infection in the pooled analysis of the included studies. Most of the pooled athletes were males. The green line corresponds to an excellent level (female: 46.8 mL/kg/min and male: 53.3 mL/kg/min) and the red line to a very poor level (female: 36.7 mL/kg/min and male: 30.9 mL/kg/min) of aerobic fitness at aged 20&#x02013;29 years, according to American College Sports Medicine (ACSM). * <italic toggle="yes">p</italic>-value was obtained by one-way ANOVA test.</p></caption><graphic xlink:href="sports-13-00040-g002" position="float"/></fig><fig position="float" id="sports-13-00040-f003"><label>Figure 3</label><caption><p>Relation between <inline-formula><mml:math id="mm52299525" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max post-COVID-19 and BMI according to CPET evaluation timing before and after 12 weeks. Athletes with CPET evaluation above 12 weeks showed a significant negative correlation between the variables (<italic toggle="yes">p</italic> = 0.01). <italic toggle="yes">p</italic>-value was obtained by the one-way ANOVA test.</p></caption><graphic xlink:href="sports-13-00040-g003" position="float"/></fig><fig position="float" id="sports-13-00040-f004"><label>Figure 4</label><caption><p>Hypothesized mechanism of vasoconstriction/vasodilation imbalance in <inline-formula><mml:math id="mm511039965" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max dynamics and performance of elite athletes post-COVID-19. The green line corresponds to the pathway that increases <inline-formula><mml:math id="mm9511035" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max, while the red line is the one that decreases <inline-formula><mml:math id="mm511852035" overflow="scroll"><mml:mrow><mml:mover><mml:mi mathvariant="normal">V</mml:mi><mml:mo>.</mml:mo></mml:mover></mml:mrow></mml:math></inline-formula>O<sub>2</sub>max.</p></caption><graphic xlink:href="sports-13-00040-g004" position="float"/></fig></floats-group></article>